Market Outlook

The U.S. Procedure-Based Medical Consumables Market is estimated at USD 44.70 billion in 2025 and is projected to reach approximately USD 101.50 billion by 2035, expanding at a CAGR of 8.55% during 2026–2035. Historical market value increased from approximately USD 31.90 billion in 2021 to USD 41.20 billion in 2024, supported by the normalization of elective procedures, accelerating outpatient surgery, higher procedural complexity, hospital inventory rebuilding, growth in minimally invasive intervention, and rising utilization of sterile single-use products. Values in this report are expressed in USD billions.

Procedure-based medical consumables represent the recurring-use products required immediately before, during, and after medical, surgical, interventional, endoscopic, diagnostic, and specialty procedures. The market includes vascular access products, needles and syringes, guidewires, introducers, procedural catheters, surgical drapes and gowns, wound-closure products, suction and drainage consumables, irrigation products, custom procedure trays, biopsy and specimen-collection devices, endoscopy accessories, anesthesia consumables, tubing sets, fluid-management products, specialty procedural kits, and related disposable components.

The market is structurally attractive because revenues are tied more closely to procedure frequency and clinical throughput than to hospital capital-equipment replacement cycles. A hospital may defer a large equipment purchase during a budget-constrained year, but it cannot conduct surgery, catheterization, biopsy, endoscopy, anesthesia, vascular access, or interventional treatment without the corresponding consumables. This gives the category a comparatively resilient recurring-revenue profile.

U.S. healthcare infrastructure provides an exceptionally large consumption base. The country operates approximately 6,100 hospitals with more than 907,000 staffed beds and approximately 35.7 million hospital admissions annually. Healthcare expenditure reached approximately USD 5.3 trillion in 2024, including about USD 1.63 trillion in hospital expenditure and more than USD 1.10 trillion in physician and clinical services expenditure. These spending pools sustain a very large installed procedural infrastructure encompassing operating rooms, catheterization laboratories, interventional radiology suites, emergency departments, endoscopy departments, outpatient departments, specialty clinics, office-based laboratories, and ambulatory surgery centers.

The outpatient transition is particularly important. More than 6,400 ambulatory surgery centers were active in the Medicare market in 2024, and these facilities treated approximately 3.4 million fee-for-service Medicare beneficiaries through around 6.4 million surgical procedures. ASC procedure volume per Medicare beneficiary continues to rise, reinforcing demand for compact procedure packs, disposable instruments, fluid-management sets, wound-closure supplies, anesthesia consumables, vascular-access devices, and products specifically configured for rapid room turnover.

Aging will provide an additional long-duration volume engine. By 2030, all members of the baby-boom generation will be older than 65, and approximately one in five Americans is projected to be of retirement age. Older patients undergo disproportionately more ophthalmic, orthopedic, cardiovascular, gastrointestinal, urological, oncological, vascular, pain-management, and diagnostic procedures. Procedure-based consumables therefore benefit not simply from population growth but from a progressively more procedure-intensive population mix.

 

Introduction

The U.S. Procedure-Based Medical Consumables Market sits at the intersection of medical-device manufacturing, clinical workflow, hospital supply-chain management, infection prevention, procedure economics, and site-of-care migration. Unlike general medical supplies, this market is defined by the direct relationship between a consumable and a clinical procedure. Products are selected based on compatibility with procedural techniques, sterility requirements, clinician preference, safety performance, reimbursement economics, and operating-room or procedure-room workflow.

The market therefore extends well beyond high-volume commodity supplies. A vascular procedure may require introducer sheaths, guidewires, syringes, stopcocks, tubing, contrast-management products, drapes, local-anesthesia supplies, closure products, dressings, and a customized procedure tray. An endoscopic procedure may consume snares, forceps, injection needles, retrieval devices, biopsy accessories, valves, tubing, cleaning accessories, and specimen-management products. A surgical procedure may require gowns, drapes, electrosurgical accessories, suction tubing, irrigation sets, wound-closure products, needles, scalpels, sponges, dressings, and multiple procedure-specific packs.

This procedure-level complexity creates substantial economic value for manufacturers capable of simplifying inventory and reducing preparation time. Procurement teams increasingly evaluate the total cost of the procedure, rather than only the unit price of a disposable device. A higher-priced consumable can be economically attractive if it shortens setup time, reduces wasted components, improves first-pass procedural success, reduces contamination risk, supports faster operating-room turnover, or avoids post-procedural complications.

Procedure economics are particularly important because U.S. providers continue to operate under labor shortages and margin pressure. Nursing time, sterile-processing capacity, supply-chain labor, room utilization, and inventory carrying cost now influence product selection almost as strongly as acquisition price. Custom procedure trays and integrated procedure packs have become strategically important because they can consolidate dozens of separately stocked components into one standardized configuration.

The market also reflects the changing clinical geography of American healthcare. Complex trauma, transplant surgery, high-acuity cardiovascular intervention, major oncologic surgery, and complicated inpatient procedures remain hospital-centered. Cataract surgery, gastrointestinal endoscopy, pain procedures, selected orthopedic operations, urological procedures, diagnostic biopsies, and other lower-acuity interventions are increasingly performed in ASCs and specialized outpatient facilities. Consumable portfolios therefore need to work across multiple economic environments rather than being designed solely for traditional hospitals.

From 2026 through 2035, market leadership will increasingly depend on the ability to connect product performance with clinical workflow and supply reliability. Manufacturers offering procedure-specific portfolios, predictable sterilization capacity, resilient U.S. distribution, customized kits, lower-waste packaging, safety-engineered products, and evidence supporting operational efficiency will be positioned more favorably than suppliers competing primarily on individual SKU pricing.

 

Key Market Drivers: What’s Fueling the U.S. Procedure-Based Medical Consumables Market Boom?

The most fundamental growth driver is the enormous volume of procedures performed across the United States. Medical consumable demand is repeatedly generated whenever a patient enters an operating room, catheterization laboratory, interventional suite, endoscopy room, imaging-guided procedure room, dialysis unit, emergency department, or ambulatory surgical facility. Unlike durable equipment, these products must be replenished continually, making procedural throughput the underlying revenue engine.

The migration of procedures from inpatient hospitals toward hospital outpatient departments and ASCs is a second major driver. The number of Medicare-participating ASCs expanded from approximately 5,760 in 2019 to more than 6,430 by 2024. This expansion is not simply creating another purchasing channel; it is changing the design requirements of consumables. ASCs frequently operate with smaller storage footprints, leaner staffing, limited central sterile-processing capacity, high daily case turnover, and strong physician influence over procurement. These conditions favor preconfigured packs, standardized disposable solutions, smaller packaging formats, rapid setup, and products that reduce staff handling.

A third driver is the increased intensity of minimally invasive medicine. Interventional cardiology, interventional radiology, peripheral vascular intervention, electrophysiology, minimally invasive surgery, endoscopic therapy, image-guided biopsy, percutaneous drainage, and office-based vascular procedures require substantial quantities of disposable access and delivery products. Even when the therapeutic device is the highest-value item in a procedure, multiple associated consumables are required to enable safe access, navigation, fluid delivery, sampling, closure, and post-procedure management.

Demographics create another durable growth platform. The American population is aging into disease categories associated with high procedure utilization. Cataract extraction, joint replacement, endoscopy, cancer biopsy, cardiac catheterization, vascular intervention, urological treatment, wound management, and pain procedures all become more common with age. Orthopedic procedural infrastructure alone is significant: the national joint-replacement registry contains data covering more than 4.4 million hip and knee arthroplasty procedures recorded between 2012 and 2024.

Women’s health represents another recurring procedural demand pool. The United States recorded more than 3.6 million births in 2024, including approximately 1.17 million cesarean deliveries, supporting continuing utilization of surgical drapes, suction products, needles, syringes, anesthesia supplies, wound-closure products, catheters, fluid-management products, and maternity procedure packs.

Infection prevention and regulatory expectations are also reinforcing single-use demand. Procedure-related products that contact sterile tissue, vascular systems, wounds, specimens, or bodily fluids require increasingly rigorous design, packaging, sterilization, traceability, and handling processes. Sterile disposable configurations can reduce the operational burden associated with reprocessing complicated reusable devices, particularly in smaller outpatient facilities.

Hospital labor economics provide another powerful demand catalyst. Procedure preparation can involve dozens of individual SKUs. Every item that must be selected, transported, opened, documented, replenished, counted, or discarded represents labor. Standardized procedure packs enable hospitals and ASCs to shift procurement from individual-product optimization toward workflow optimization. As nursing and technical labor remain expensive, the financial value of saving even several minutes of preparation and turnover time across thousands of annual procedures can materially exceed small differences in component pricing.

Supply-chain resilience has simultaneously become a purchasing criterion. Quality issues affecting imported syringes in 2024 demonstrated how a seemingly basic consumable can disrupt procedure kits and clinical operations across multiple suppliers. Health systems are consequently examining manufacturing origin, secondary suppliers, sterilization redundancy, safety stock, domestic distribution capacity, recall management, and supplier visibility more closely than before.

Finally, reimbursement is encouraging providers to manage the entire procedure episode more efficiently. Hospitals and ASCs generally cannot pass every incremental consumable cost directly to payers. Products must therefore justify their economics within bundled procedural reimbursement. This favors consumables that reduce complication risk, simplify staffing, shorten procedure time, enable outpatient care, and improve predictability.

 

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation in procedure-based consumables is increasingly less about creating another basic disposable and more about improving the entire procedural workflow. The strongest product-development programs are targeting safety, preparation time, component consolidation, traceability, waste reduction, clinician ergonomics, and compatibility with minimally invasive procedures.

Custom procedure trays and procedure-specific kits are becoming more sophisticated. Traditional packs largely bundled commodity supplies. New configurations increasingly incorporate specialty components matched to specific surgical, vascular, endoscopic, biopsy, anesthesia, orthopedic, and interventional workflows. Manufacturers capable of working directly with health systems to rationalize components can reduce unused supplies while increasing standardization across multiple facilities.

Vascular access innovation is centered on needle safety, reduced blood exposure, low-dead-space designs, improved catheter materials, securement, antimicrobial protection, closed systems, and compatibility with infusion platforms. Because vascular access touches almost every procedural department, incremental improvements can generate substantial clinical and economic value at scale.

Surgical consumables are evolving toward advanced wound closure, absorbable materials, antimicrobial technologies, topical hemostasis, improved adhesives, atraumatic dressings, fluid control, smoke-management accessories, and minimally invasive access products. Hospitals increasingly consider the downstream consequences of closure and wound-management choices because surgical-site complications can create substantial costs well after the consumable itself has been used.

The endoscopy category is moving toward increasingly procedure-specific disposable accessories. Biopsy forceps, snares, injection needles, retrieval devices, clips, guidewires, valves, distal attachments, specimen tools, and specialty therapeutic accessories are becoming integral to the economics of gastrointestinal and pulmonary endoscopy. Growth in therapeutic endoscopy increases consumable value per case because procedures require more specialized accessories than routine diagnostic examinations.

Diagnostic and interventional biopsy products are becoming more precise, image-compatible, and specialty-specific. Breast, lung, liver, prostate, bone, and soft-tissue procedures increasingly rely on dedicated needles, coaxial systems, localization products, specimen containers, and marker technologies. Manufacturers are focusing on better tissue acquisition while reducing the number of passes and improving specimen integrity.

Digital supply-chain integration is another emerging differentiator. UDI tracking, RFID-enabled inventory, automated replenishment, barcode scanning, procedure-level consumption analytics, and integration with hospital materials-management systems can provide visibility into which products are opened, wasted, expired, recalled, or used by procedural service line. Over time, this information will enable health systems to negotiate purchasing contracts based on procedure economics rather than historical inventory consumption.

Sustainability is also moving into product design. Procedure areas generate significant volumes of packaging and disposable material. Buyers are increasingly examining reduced packaging, recyclable components, alternative sterilization technologies, lighter materials, right-sized custom packs, and regulated reprocessing opportunities. The challenge for manufacturers is to reduce environmental impact without compromising sterility, performance, barrier integrity, or workflow convenience.

Sterilization itself has become an innovation priority. Ethylene oxide remains essential for large volumes of temperature- and moisture-sensitive medical devices, with approximately 20 billion U.S. medical devices—around half of the national device supply—estimated to undergo EtO sterilization each year. Regulatory pressure surrounding EtO emissions is encouraging manufacturers to evaluate lower-EtO cycles, alternative sterilization modalities, packaging redesign, irradiation compatibility, and redundancy across sterilization networks.

 

Segmentation Insights

The U.S. Procedure-Based Medical Consumables Market is segmented on the basis of product category, procedure type, sterility and configuration, end user, and region.

 

By Product Category

Catheters, Guidewires and Procedural Access Consumables

Catheters, guidewires, introducer sheaths, access needles, dilators, stopcocks, manifolds, extension lines, drainage catheters, and related products represent the largest high-value procedural consumables group, estimated at approximately USD 13.40 billion in 2025. Demand is supported by interventional cardiology, vascular procedures, electrophysiology, interventional radiology, anesthesia, urology, critical care, and minimally invasive treatment. Growth is shifting toward specialty-coated products, lower-profile access systems, complex intervention, and devices optimized for outpatient workflows.

Surgical and Wound-Closure Consumables

This segment is estimated at approximately USD 9.80 billion in 2025 and includes sutures, staples, surgical adhesives, topical closure products, dressings, drains, suction products, hemostatic consumables, surgical sponges, blades, and specialty wound-management products. Procedure volumes remain the central demand driver, while premium expansion is increasingly tied to infection reduction, atraumatic closure, faster healing, advanced hemostasis, minimally invasive surgery, and reduced post-operative complications.

Procedure Packs, Drapes, Gowns and Barrier Products

Procedure trays, custom surgical packs, sterile drapes, procedure gowns, covers, wraps, protective barriers, and related products generated an estimated USD 8.10 billion in 2025. Growth is increasingly driven by customization rather than simple unit volume. Large health systems are standardizing procedure packs across hospitals and ASCs to reduce SKU complexity, nursing preparation time, inventory handling, and procedural waste.

Injection, Infusion and Fluid-Management Consumables

Syringes, needles, infusion sets, extension tubing, connectors, administration sets, irrigation products, collection systems, and other fluid-management consumables accounted for approximately USD 7.40 billion in 2025. This is a mature but highly resilient segment because these products are required across nearly every procedure setting. Safety-engineered designs, needleless connections, closed systems, low-dead-space syringes, and secure fluid pathways are sustaining value growth.

Biopsy, Sampling, Endoscopy and Specialty Procedure Consumables

The remaining approximately USD 6.00 billion encompasses biopsy needles, specimen-management products, endoscopic accessories, ophthalmic disposables, urology consumables, anesthesia breathing accessories, gynecological procedure supplies, renal procedure sets, and other specialty products. Although fragmented, this category offers attractive growth because many subsegments are procedure-specific and therefore provide greater pricing differentiation than generalized commodity consumables.

 

By Procedure Type

Surgical Procedures

Surgery represents the largest procedural demand pool, accounting for an estimated USD 15.20 billion of consumable revenue in 2025. General surgery, orthopedics, cardiovascular surgery, neurosurgery, gynecology, ENT, ophthalmology, oncology, plastic surgery, and trauma procedures consume multiple disposable products per case. The economic shift toward minimally invasive and ambulatory surgery is changing the mix from large inpatient packs toward procedure-specific, compact, highly standardized disposable configurations.

Interventional and Catheter-Based Procedures

Interventional procedures generated an estimated USD 10.80 billion in 2025 and are expected to be among the fastest-growing applications through 2035. Cardiac catheterization, electrophysiology, peripheral vascular intervention, neurovascular procedures, interventional oncology, embolization, image-guided drainage, venous intervention, and structural procedures consume significant quantities of access devices, guidewires, catheters, syringes, tubing, closure products, dressings, and sterile barriers.

Endoscopic Procedures

Endoscopy accounted for approximately USD 7.50 billion in 2025. Gastrointestinal endoscopy represents the largest component, complemented by bronchoscopy, urological endoscopy, arthroscopy, and other scope-based procedures. Consumable intensity is increasing as endoscopy evolves from primarily diagnostic visualization toward biopsy, lesion removal, hemostasis, tissue resection, dilation, stenting, drainage, and other therapeutic interventions.

Diagnostic, Biopsy and Image-Guided Procedures

Diagnostic and image-guided interventions accounted for approximately USD 5.40 billion in 2025. Breast biopsy, prostate biopsy, lung biopsy, liver biopsy, bone biopsy, fine-needle aspiration, image-guided drainage, and other minimally invasive diagnostic procedures are important recurring markets. Demand is supported by cancer screening, earlier diagnosis, greater imaging utilization, and the movement of selected interventions into outpatient and office settings.

Specialty Procedures

Specialty applications, including ophthalmology, urology, renal care, obstetrics and gynecology, pain management, dermatologic surgery, podiatry, dental surgery, and other procedural areas, accounted for approximately USD 5.80 billion in 2025. These markets are individually narrower but collectively significant. Many are particularly well suited to ASCs and physician-owned facilities, providing strong growth potential for manufacturers with procedure-specific kits and compact distribution models.

 

By Sterility and Configuration

Sterile Single-Use Consumables

Sterile single-use products dominate the market and represented approximately USD 32.80 billion, or more than 73% of 2025 revenue. Products entering sterile fields, blood vessels, internal tissue, surgical wounds, or other high-risk environments generally require validated sterile configurations. Growth is supported by infection-control expectations, outpatient expansion, increasingly complex disposable catheter systems, and reduced willingness to place unnecessary reprocessing burden on clinical staff.

Custom Procedure Trays and Integrated Kits

Custom procedure trays accounted for approximately USD 6.10 billion in 2025 and are expected to expand faster than traditional commodity supplies. Their value proposition lies in workflow consolidation. One customized pack can replace individual picking and opening of dozens of items, improving setup consistency while reducing inventory and staff handling.

Non-Sterile Procedure Support Consumables

Non-sterile or externally used procedure-support products represented an estimated USD 3.80 billion in 2025. This category includes selected protective products, preparation supplies, examination components, external tubing accessories, and support materials. Price competition remains significant, making procurement scale, logistics reliability, and private-label strategies important competitive factors.

Regulated Reprocessed Single-Use Devices

Reprocessed single-use devices represent a smaller estimated USD 2.00 billion economic pool but play an important role in hospital cost reduction and sustainability strategies. U.S. regulation requires eligible reprocessed single-use devices to meet applicable safety, performance, labeling, validation, and premarket requirements. Adoption is strongest where devices retain sufficient functionality after validated reprocessing and where savings justify collection and processing logistics.

 

By End User

Hospitals and Integrated Health Systems

Hospitals remain the dominant purchasers and accounted for an estimated USD 26.40 billion in 2025, or approximately 59% of market value. Hospitals manage the widest procedural mix and consume products across operating rooms, emergency departments, catheterization labs, interventional suites, endoscopy departments, labor and delivery, critical care, dialysis, imaging, and inpatient nursing units.

Large integrated delivery networks increasingly negotiate enterprise contracts rather than facility-level agreements. These buyers evaluate suppliers on clinical standardization, distribution continuity, recall responsiveness, custom-pack capability, pricing transparency, inventory support, and integration with major group purchasing organizations.

Ambulatory Surgery Centers

ASCs represented approximately USD 8.90 billion in 2025 and are expected to be the fastest-growing major end-user segment. The number of Medicare-participating ASCs increased by more than 2% annually during the first half of the decade, while procedure volumes also expanded. Ophthalmology, orthopedics, gastrointestinal procedures, pain management, urology, ENT, gynecology, and selected cardiovascular procedures provide major consumption opportunities.

ASC economics reward simplified inventories, smaller order quantities, rapid room turnover, and predictable procedure costs. Suppliers capable of offering targeted specialty packs instead of large hospital-oriented portfolios are particularly well positioned.

Specialty Clinics and Office-Based Laboratories

Specialty clinics and office-based labs are becoming increasingly relevant for vascular intervention, venous procedures, urology, dermatology, pain management, cardiology, interventional radiology, and minor surgery. The segment accounted for approximately USD 4.50 billion in 2025. Physician ownership can shorten purchasing cycles but creates strong sensitivity to per-case economics.

Endoscopy and Diagnostic Procedure Centers

Dedicated endoscopy, imaging, biopsy, and diagnostic procedure centers generated approximately USD 2.70 billion in 2025. These facilities typically run repetitive, standardized procedure schedules and therefore offer attractive opportunities for procedure-specific consumables, predictable replenishment programs, and standardized packs.

Other Procedural Care Settings

Urgent care facilities, dialysis environments, maternity centers, dental surgical settings, military and federal facilities, and other procedural sites represented approximately USD 2.20 billion in 2025. Although fragmented, these users provide significant opportunities for distributors and manufacturers with broad national logistics infrastructure.

 

Regional Insights: Where the Market is Growing Fastest

The U.S. Procedure-Based Medical Consumables Market is geographically segmented into the South, Northeast, West, and Midwest. Market performance varies considerably according to population growth, age mix, hospital concentration, surgical infrastructure, ASC penetration, chronic disease burden, specialist availability, payer mix, and the speed at which procedures migrate into outpatient settings.

The South is the largest regional market, while the West is projected to record the fastest growth through 2035. The Northeast generates disproportionately high value from sophisticated tertiary and academic procedures, while the Midwest provides a large and stable procedural base supported by established integrated health systems.

South

The South represented approximately USD 16.80 billion in 2025, equivalent to about 37.6% of the national market, and is projected to approach USD 39.60 billion by 2035, representing an estimated regional CAGR of about 8.95%.

Texas and Florida are the region’s largest state opportunities. Texas combines rapid population growth with major procedural markets in Houston, Dallas-Fort Worth, Austin, and San Antonio. Large academic institutions, integrated hospital systems, trauma centers, cardiovascular networks, orthopedic facilities, cancer centers, and an expanding ASC base sustain heavy demand for surgical packs, vascular access products, interventional consumables, fluid-management systems, wound-closure products, and specialty disposables.

Florida is structurally attractive because of its older population and large number of Medicare beneficiaries. Ophthalmology, gastroenterology, cardiology, urology, orthopedics, wound care, and outpatient surgery are particularly important. The state’s healthcare economy strongly supports consumables aligned with cataract procedures, endoscopy, cardiovascular intervention, joint procedures, biopsy, pain management, and ambulatory surgery.

North Carolina, Georgia, Tennessee, and Virginia represent the second growth tier. Major metro areas such as Charlotte, Raleigh-Durham, Atlanta, Nashville, Memphis, Richmond, and Northern Virginia contain expanding procedural infrastructure and large health systems. North Carolina and Tennessee also benefit from significant healthcare corporate activity, while Georgia and Virginia continue to gain population.

Maryland combines sophisticated academic and federal healthcare infrastructure with dense specialist networks. South Carolina is expanding alongside population migration and retirement communities. Kentucky and West Virginia have substantial chronic disease burdens that support cardiovascular, renal, vascular, wound, and surgical demand.

Alabama, Mississippi, Louisiana, Arkansas, and Oklahoma represent smaller absolute markets but high underlying clinical need. Rural access limitations can constrain advanced procedure availability, encouraging consolidation into regional referral centers. For manufacturers, this creates an opportunity for hub-and-spoke distribution models that can service high-volume tertiary centers as well as smaller community hospitals.

Across the South, the strongest growth opportunities through 2035 will come from ASC expansion, cardiovascular and peripheral intervention, endoscopy, orthopedics, cancer diagnostics, cataract surgery, dialysis-related procedures, and standardized procedure packs. The region’s population trajectory should enable it to remain the largest U.S. consumables market throughout the forecast period.

West

The West accounted for approximately USD 9.40 billion in 2025 and is projected to reach about USD 23.60 billion by 2035, corresponding to an estimated 9.64% CAGR, the fastest of the four regions.

California dominates regional value. Its scale is reinforced by a very large population, sophisticated academic medical centers, extensive outpatient infrastructure, major integrated health systems, and rapid adoption of new procedural technology. California also combines clinical demand with medtech development, enabling new disposable access systems, surgical technologies, endoscopy accessories, biopsy products, digital supply tools, and sustainability-oriented solutions to obtain early evaluation.

Washington and Oregon provide sophisticated hospital purchasing environments where health systems frequently emphasize evidence-based standardization, sustainability, digital supply management, and procedural quality. These markets are particularly attractive for premium consumables capable of demonstrating lower waste or reduced staff handling.

Arizona and Nevada are among the most important demographic growth markets. Population expansion and increasing numbers of retirees are supporting new hospital construction, ambulatory surgery capacity, cardiovascular care, orthopedics, ophthalmology, urology, and gastrointestinal procedures. These states offer attractive long-term opportunities for both premium clinical products and standardized high-volume procedure supplies.

Colorado and Utah have strong integrated delivery networks and younger growth demographics combined with expanding specialty-care infrastructure. Denver, Salt Lake City, and surrounding markets have become important centers for orthopedics, cardiovascular intervention, outpatient surgery, and specialty procedures.

New Mexico, Idaho, Montana, and Wyoming are smaller but strategically relevant markets where geographic dispersion increases the importance of reliable distribution and efficient inventory management. Alaska and Hawaii face unique freight, storage, and supply-continuity challenges, creating stronger purchasing preference for suppliers capable of maintaining dependable regional inventories.

The West should gain national market share through 2035 as healthcare providers adopt more ambulatory procedures, digital inventory systems, lower-waste procedure packs, minimally invasive technologies, and differentiated single-use accessories.

Northeast

The Northeast generated approximately USD 10.40 billion in 2025 and is projected to reach around USD 21.70 billion by 2035, representing an estimated 7.63% CAGR.

New York is the largest market in the region. New York City and surrounding metropolitan areas generate high procedural volumes across complex surgery, oncology, cardiovascular intervention, transplant care, gastrointestinal procedures, orthopedics, and specialty medicine. Large hospital networks provide substantial enterprise contracting opportunities, although suppliers face rigorous value-analysis requirements.

Massachusetts has a smaller population but unusually high strategic influence because of its concentration of academic medical centers, biomedical research, specialty clinicians, medtech innovation, and clinical trials. Premium consumables often receive early evaluation in these environments before broader community adoption.

Pennsylvania represents another major market, with Philadelphia and Pittsburgh supporting large integrated health systems and extensive tertiary-care infrastructure. New Jersey combines dense population, high healthcare utilization, strong life-sciences activity, and proximity to both New York and Philadelphia markets.

Connecticut and Delaware provide smaller but high-value procedure markets supported by strong insurance coverage and access to major regional referral networks. Rhode Island, Maine, New Hampshire, and Vermont have smaller absolute populations but significant aging-related demand. Ophthalmic, orthopedic, endoscopic, cardiovascular, wound-care, and urological consumables are particularly relevant in the older New England markets.

The Northeast is unlikely to match the population-driven growth of the South or West, but its high procedure complexity, academic concentration, and specialist density support premium product penetration. Manufacturers introducing advanced closure technologies, procedure-specific kits, specialty catheters, biopsy devices, minimally invasive accessories, and evidence-supported clinical products should continue to view the region as an important launch market.

Midwest

The Midwest represented approximately USD 8.10 billion in 2025 and is forecast to reach approximately USD 16.60 billion by 2035, reflecting an estimated regional CAGR of 7.44%.

Illinois is the largest regional market, driven primarily by Chicago’s academic and community healthcare ecosystem. The state supports substantial surgical, cardiovascular, endoscopy, oncology, orthopedic, and diagnostic volumes and provides meaningful opportunities for enterprise supply contracting.

Ohio has one of the country’s strongest concentrations of integrated health systems and specialty institutions. Cleveland, Columbus, and Cincinnati provide substantial procedural volumes, especially in cardiovascular medicine, surgery, oncology, and orthopedics. Michigan similarly maintains a large hospital and procedural base supported by Detroit, Ann Arbor, Grand Rapids, and other regional centers.

Minnesota is strategically significant beyond its population because of its long-standing medtech manufacturing ecosystem and advanced provider institutions. It remains an important market for clinical evaluation, procedural innovation, and sophisticated hospital procurement.

Indiana, Wisconsin, and Missouri provide stable procedural demand across community hospitals, tertiary referral institutions, ASCs, and specialty practices. Iowa, Kansas, and Nebraska have smaller but established regional networks in which larger hospitals serve broad rural catchment areas.

North Dakota and South Dakota remain relatively small markets in revenue terms, but centralized referral models can produce meaningful procedure concentration at leading regional institutions. Reliable logistics and product standardization are particularly important in these geographically dispersed markets.

The Midwest should remain a dependable market for mature consumables while generating selective premium growth in minimally invasive intervention, specialty surgery, custom procedure packs, and outpatient orthopedics. Price sensitivity is generally stronger than in major coastal markets, making clinical education, supply reliability, contracting flexibility, and demonstrable per-procedure savings particularly important.

 

Key Market Players

The U.S. Procedure-Based Medical Consumables competitive environment is fragmented at the product level but increasingly consolidated at the health-system contracting level. Large suppliers benefit from extensive manufacturing networks, national distribution, custom procedure tray capabilities, breadth across clinical departments, and relationships with major group purchasing organizations. Specialized manufacturers compete by offering clinically differentiated products within cardiovascular access, endoscopy, wound closure, biopsy, surgery, anesthesia, urology, renal care, and other specialty categories.

Some of the most relevant companies operating across the U.S. procedure-based medical consumables ecosystem include Medline Industries, Cardinal Health, Becton, Dickinson and Company, Baxter International, B. Braun Medical, Johnson & Johnson MedTech/Ethicon, Teleflex, Terumo Medical Corporation, ICU Medical, Owens & Minor, Mölnlycke Health Care, Smith+Nephew, Solventum, Cook Medical, Merit Medical Systems, Boston Scientific, Abbott, Stryker, Olympus Corporation of the Americas, Fresenius Medical Care, Nipro Medical Corporation, Convatec, Integra LifeSciences, Ansell, and McKesson Medical-Surgical.

Medline, Cardinal Health, BD, Baxter, B. Braun, and Owens & Minor are particularly important in broad hospital consumables and distribution ecosystems. Their scale allows them to compete across multiple clinical departments while supporting national inventory, private-label portfolios, procedural kits, and IDN contracting.

Johnson & Johnson MedTech, Smith+Nephew, Stryker, Integra, Mölnlycke, and Convatec have greater exposure to surgical, closure, wound-management, and operating-room applications. Teleflex, Terumo, Cook Medical, Merit Medical, Boston Scientific, and Abbott participate more heavily in catheter-based intervention, procedural access, diagnostic, cardiovascular, or specialty consumables.

Olympus is strategically important in endoscopic procedural accessories, while Fresenius and Nipro maintain strong exposure to renal and fluid-management consumables. ICU Medical and B. Braun are significant in infusion, vascular access, administration, and fluid-delivery systems. Ansell is important in surgical protection and procedure environments, while Solventum maintains exposure to wound, surgical, and infection-prevention categories.

Competition through 2035 will increasingly occur at three levels simultaneously: the individual device, the procedure bundle, and the enterprise contract. A company can have a technically superior product yet lose business if it cannot provide national distribution, sterilization continuity, data integration, pricing transparency, and contracting flexibility.

Large health systems will continue rationalizing the number of suppliers they manage. This favors manufacturers capable of covering multiple procedural categories. However, specialized companies retain meaningful opportunity when their products improve clinical outcomes, reduce procedure time, solve a clear workflow problem, or address a highly specialized procedure where broad-line suppliers lack clinical depth.

 

Recent Developments

The U.S. market has entered a period in which supply-chain quality is receiving almost as much attention as product innovation. During 2024, federal regulators intensified scrutiny of certain plastic syringes manufactured in China following concerns involving leaks, breakage, dimensional inconsistency, and performance failures. Multiple warning letters, recalls, and import actions followed. Because syringes are components of numerous procedural kits, the situation demonstrated how component-level quality failures can propagate through broader convenience-kit and procedure-pack supply chains.

Sterilization policy is another major strategic development. In 2024, new federal air-emission requirements for commercial ethylene oxide sterilization facilities sought reductions exceeding 90% in EtO emissions. The requirements affected approximately 90 commercial sterilization facilities. During 2026, federal authorities proposed reconsidering elements of the rule because of concerns surrounding medical-device supply continuity. The policy debate is commercially important because EtO is used to sterilize roughly half of U.S. medical devices, including many catheters, surgical kits, gowns, drapes, syringes, and other procedure-based products.

This environment is encouraging large manufacturers to diversify sterilization capacity, redesign packaging, validate alternative technologies, and strengthen business-continuity plans. Sterilization availability is therefore becoming a strategic procurement issue rather than a manufacturing issue invisible to hospital buyers.

Outpatient procedure migration continues to reshape product development. Medicare-participating ASCs reached approximately 6,436 facilities in 2024, representing roughly 2.2% year-over-year growth. Around 6.4 million ASC procedures were delivered to Medicare fee-for-service beneficiaries during the year. Manufacturers increasingly design packs, packaging, order quantities, and distribution models specifically for this environment.

Supply availability remains uneven within specialty consumables. As of mid-2026, federal shortage monitoring continued to identify selected procedural products, including stereotactic breast-biopsy needles and endoscopic vessel-harvesting systems, as constrained categories. These shortages reinforce the strategic importance of dual sourcing and resilient domestic inventories for products with limited substitutes.

Orthopedic procedure volumes are also expanding the addressable pool for surgical and ambulatory consumables. The U.S. joint replacement registry’s 2025 reporting cycle analyzed more than 4.4 million hip and knee arthroplasty procedures captured from 2012 through 2024, highlighting the scale of just one procedure-intensive clinical category.

The competitive landscape is consequently shifting from low-cost sourcing toward resilient value sourcing. Price remains important, but hospitals increasingly understand that a low-priced item that is unavailable, recalled, incorrectly configured, or operationally inefficient can generate costs far beyond its purchase price.

 

Conclusion

The U.S. Procedure-Based Medical Consumables Market Size & Share is positioned to expand from approximately USD 44.70 billion in 2025 to USD 101.50 billion by 2035, representing a CAGR of 8.55% during 2026–2035.

The market’s strength lies in its direct connection to the recurring economics of U.S. medical procedures. Every expansion in surgical throughput, endoscopic activity, image-guided intervention, catheter-based treatment, ambulatory surgery, biopsy, vascular access, and specialty procedures creates incremental consumable demand. Unlike many capital-device markets, procedure-based supplies do not depend primarily on replacement cycles; utilization itself generates replenishment.

The most attractive growth areas will be catheter-based procedural consumables, customized procedure packs, advanced wound-closure products, safety-engineered vascular access devices, specialty endoscopy accessories, biopsy systems, minimally invasive procedure sets, outpatient surgery consumables, and products that simplify clinical workflows.

Hospitals will remain the largest customer segment, but ASCs will capture a progressively larger share of incremental market growth. Manufacturers should therefore avoid treating ambulatory facilities as scaled-down hospitals. The winning ASC offering will require different packaging, order quantities, procedure kits, contracting economics, field support, and inventory strategies.

Regionally, the South will remain the largest market, increasing from approximately USD 16.80 billion in 2025 to USD 39.60 billion by 2035. The West will be the fastest-growing region, expanding from approximately USD 9.40 billion to USD 23.60 billion. The Northeast will maintain a disproportionate role in premium clinical adoption, while the Midwest will remain a large and stable market where value demonstration and supply reliability are especially important.

For manufacturers, distributors, investors, health systems, procurement organizations, and market entrants, the decisive strategic question is not simply how many medical consumables the United States will purchase. The more important questions are which procedures will migrate to outpatient care, which consumables will gain value per procedure, which products will be standardized across health systems, how sterilization and sourcing requirements will change, and which suppliers can reduce the total cost of conducting a procedure.

By 2035, competitive advantage will increasingly belong to companies capable of combining clinically differentiated consumables with procedure-level economics, resilient supply networks, customized configurations, infection-control performance, transparent sourcing, and measurable improvements in clinical workflow.

 

TABLE OF CONTENT

1. U.S. Procedure-Based Medical Consumables Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Analytical Frameworks & Forecasting Models
1.3.6. Data Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Market Ecosystem Overview
1.6. Stakeholder Analysis
1.6.1. Procedure-Based Medical Consumables Manufacturers
1.6.2. Raw Material, Component and Packaging Suppliers
1.6.3. Contract Manufacturers and Sterilization Service Providers
1.6.4. Hospitals and Integrated Delivery Networks
1.6.5. Ambulatory Surgery Centers
1.6.6. Specialty Clinics and Office-Based Laboratories
1.6.7. Endoscopy and Diagnostic Procedure Centers
1.6.8. Group Purchasing Organizations and Medical Distributors
1.6.9. Payers, Regulators and Clinical Decision-Makers
What this section provides: This section defines the boundaries of the U.S. procedure-based medical consumables market, study scope, methodology, assumptions, inclusion and exclusion criteria, and stakeholder ecosystem so clients understand how market value, procedure-linked demand, and forecasts are measured and validated.

2. U.S. Procedure-Based Medical Consumables Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. Procedure Volume and Consumable Utilization Snapshot
2.8. High-Growth Opportunity Areas
2.9. Hospital vs. Ambulatory Procedure Demand Outlook
2.10. Key Strategic Findings for Manufacturers and Investors
What this section provides: This section gives decision-makers a concise view of market size, historical performance, forecast growth, procedure-volume trends, care-setting migration, competitive intensity, and the most commercially attractive consumable categories through 2035.

3. U.S. Procedure-Based Medical Consumables Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. Rising U.S. Surgical and Interventional Procedure Volumes
3.1.2. Migration of Procedures Toward Ambulatory Surgery Centers
3.1.3. Aging Population and Increasing Procedure Intensity
3.1.4. Growth of Minimally Invasive and Catheter-Based Procedures
3.1.5. Expansion of Gastrointestinal Endoscopy and Therapeutic Endoscopy
3.1.6. Rising Demand for Sterile Single-Use Procedure Products
3.1.7. Infection Prevention and Cross-Contamination Reduction
3.1.8. Custom Procedure Tray and Integrated Kit Adoption
3.1.9. Hospital Labor Shortages and Procedure Workflow Optimization
3.1.10. Growth in Diagnostic Biopsy and Image-Guided Interventions
3.2. Restraints and Their Impact Analysis
3.2.1. Commodity Pricing Pressure and GPO Negotiating Power
3.2.2. Raw Material and Manufacturing Cost Volatility
3.2.3. Product Recalls and Quality-Control Risk
3.2.4. Sterilization Capacity Constraints
3.2.5. Environmental Concerns Around Single-Use Medical Products
3.2.6. Hospital Margin Pressure and Consumable Standardization
3.2.7. Dependence on Global Manufacturing and Imported Components
3.3. Opportunities and Their Impact Analysis
3.3.1. Custom Procedure Packs for High-Volume Procedures
3.3.2. Procedure-Specific Consumables for Ambulatory Surgery Centers
3.3.3. Single-Use and Safety-Engineered Vascular Access Products
3.3.4. Advanced Surgical Closure and Hemostasis Consumables
3.3.5. Specialty Endoscopy and Therapeutic Procedure Accessories
3.3.6. Image-Guided Biopsy and Sampling Consumables
3.3.7. Domestic Manufacturing and Supply-Chain Localization
3.3.8. Sustainable and Lower-Waste Procedure Consumables
3.3.9. Digitally Trackable and Inventory-Connected Consumables
3.4. Challenges and Their Impact Analysis
3.5. Patent & Innovation Analysis, 2021–2025
3.6. Clinical Workflow Economics Analysis
3.6.1. Consumable Cost per Procedure
3.6.2. Procedure Preparation and Room Turnover Economics
3.6.3. Staff Time and Inventory Handling Costs
3.6.4. Procedure Pack Standardization Economics
3.6.5. Waste Reduction and Unused Component Analysis
3.7. Hospital and ASC Consumables Procurement Behavior Analysis
3.7.1. Clinical Preference vs. Standardization
3.7.2. Value Analysis Committee Evaluation
3.7.3. GPO and IDN Contract Influence
3.7.4. Physician Preference in Ambulatory Settings
3.7.5. Supply Availability and Product Substitution Decisions
What this section provides: This section explains the procedural, demographic, clinical, economic, reimbursement, supply-chain, and operational forces shaping consumables demand and helps clients evaluate both market upside and execution risks.

4. U.S. Procedure-Based Medical Consumables Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers
4.2.3. Bargaining Power of Suppliers
4.2.4. Substitution Risk
4.2.5. Competitive Rivalry
4.3. Pricing Trend Analysis by Region, 2025–2035
4.4. Value Chain & Supply Chain Analysis
4.4.1. Raw Material Suppliers
4.4.2. Component Manufacturers
4.4.3. Medical Consumables Manufacturers
4.4.4. Sterilization Providers
4.4.5. Packaging and Kit Assembly Providers
4.4.6. GPOs and National Distributors
4.4.7. Hospitals, ASCs and Specialty Procedure Centers
4.5. Impact of Digitalization on Procedural Supply Management
4.5.1. UDI-Based Product Tracking
4.5.2. RFID and Smart Inventory Systems
4.5.3. Automated Replenishment
4.5.4. Procedure-Level Utilization Analytics
4.5.5. Expiration and Recall Management
4.6. Application & Innovation Landscape
4.7. FDA Regulatory Framework Analysis
4.8. CMS Reimbursement and Procedure Payment Landscape
4.9. Medical Device Sterilization Regulatory Landscape
4.9.1. Ethylene Oxide Sterilization
4.9.2. Radiation Sterilization
4.9.3. Alternative Sterilization Technologies
4.9.4. Sterilization Capacity and Supply Continuity
4.10. Import/Export Restrictions & Tariff Impact
4.11. Government Initiatives and Healthcare Quality Programs
4.12. Impact of Escalating Geopolitical and Trade Tensions
4.13. Sustainability and Medical Waste Management Analysis
4.14. Hospital Value Analysis Committee Decision Framework
What this section provides: This section gives clients a comprehensive view of regulation, reimbursement, sterilization, pricing, sustainability, supply chains, digital inventory management, trade exposure, and hospital procurement dynamics affecting procedure-based consumables.

5. U.S. Procedure-Based Medical Consumables Market – By Product Category

5.1. Overview
5.1.1. Segment Share Analysis, By Product Category, 2025 & 2035 (%)
5.1.2. Catheters, Guidewires and Procedural Access Consumables
5.1.2.1. Procedural Catheters
5.1.2.2. Guidewires
5.1.2.3. Introducer Sheaths
5.1.2.4. Access Needles
5.1.2.5. Dilators
5.1.2.6. Stopcocks and Manifolds
5.1.2.7. Drainage Catheters
5.1.2.8. Extension Lines and Accessory Tubing
5.1.2.9. Other Procedural Access Consumables
5.1.3. Surgical and Wound-Closure Consumables
5.1.3.1. Sutures
5.1.3.2. Surgical Staples
5.1.3.3. Surgical Adhesives and Sealants
5.1.3.4. Hemostatic Consumables
5.1.3.5. Surgical Blades and Scalpels
5.1.3.6. Surgical Sponges
5.1.3.7. Surgical Drains
5.1.3.8. Wound Dressings
5.1.3.9. Other Surgical Consumables
5.1.4. Procedure Packs, Drapes, Gowns and Barrier Products
5.1.4.1. Custom Procedure Trays
5.1.4.2. Standard Procedure Packs
5.1.4.3. Surgical Drapes
5.1.4.4. Procedural Gowns
5.1.4.5. Equipment Covers
5.1.4.6. Sterile Wraps and Barrier Products
5.1.4.7. Other Procedure-Pack Components
5.1.5. Injection, Infusion and Fluid-Management Consumables
5.1.5.1. Syringes
5.1.5.2. Needles
5.1.5.3. Infusion and Administration Sets
5.1.5.4. Extension Tubing
5.1.5.5. Needleless Connectors
5.1.5.6. Irrigation Sets
5.1.5.7. Suction and Collection Systems
5.1.5.8. Other Fluid-Management Consumables
5.1.6. Biopsy, Sampling, Endoscopy and Specialty Procedure Consumables
5.1.6.1. Biopsy Needles and Systems
5.1.6.2. Specimen Collection and Management Products
5.1.6.3. Endoscopic Biopsy Forceps
5.1.6.4. Endoscopic Snares
5.1.6.5. Injection Needles and Retrieval Devices
5.1.6.6. Endoscopic Clips and Accessories
5.1.6.7. Ophthalmic Procedure Consumables
5.1.6.8. Urological Procedure Consumables
5.1.6.9. Anesthesia Procedure Consumables
5.1.6.10. Gynecological Procedure Consumables
5.1.6.11. Renal Procedure Consumables
5.1.6.12. Other Specialty Consumables
What this section provides: This section identifies the procedure-based consumable categories generating the largest revenue pools and highlights which products are expected to gain share through increased procedure volumes, clinical specialization, and premium single-use adoption.

6. U.S. Procedure-Based Medical Consumables Market – By Procedure Type

6.1. Overview
6.1.1. Segment Share Analysis, By Procedure Type, 2025 & 2035 (%)
6.1.2. Surgical Procedures
6.1.2.1. General Surgery
6.1.2.2. Orthopedic Surgery
6.1.2.3. Cardiovascular Surgery
6.1.2.4. Neurosurgery
6.1.2.5. Gynecological Surgery
6.1.2.6. Ophthalmic Surgery
6.1.2.7. ENT Surgery
6.1.2.8. Oncology Surgery
6.1.2.9. Plastic and Reconstructive Surgery
6.1.2.10. Trauma Surgery
6.1.3. Interventional and Catheter-Based Procedures
6.1.3.1. Interventional Cardiology
6.1.3.2. Electrophysiology
6.1.3.3. Peripheral Vascular Intervention
6.1.3.4. Neurovascular Intervention
6.1.3.5. Interventional Radiology
6.1.3.6. Interventional Oncology
6.1.3.7. Venous Procedures
6.1.3.8. Image-Guided Drainage Procedures
6.1.4. Endoscopic Procedures
6.1.4.1. Gastrointestinal Endoscopy
6.1.4.2. Colonoscopy
6.1.4.3. Upper GI Endoscopy
6.1.4.4. ERCP
6.1.4.5. EUS Procedures
6.1.4.6. Bronchoscopy
6.1.4.7. Urological Endoscopy
6.1.4.8. Other Endoscopic Procedures
6.1.5. Diagnostic, Biopsy and Image-Guided Procedures
6.1.5.1. Breast Biopsy
6.1.5.2. Prostate Biopsy
6.1.5.3. Lung Biopsy
6.1.5.4. Liver Biopsy
6.1.5.5. Bone Biopsy
6.1.5.6. Soft-Tissue Biopsy
6.1.5.7. Fine-Needle Aspiration
6.1.5.8. Image-Guided Diagnostic Procedures
6.1.6. Specialty Procedures
6.1.6.1. Ophthalmology
6.1.6.2. Urology
6.1.6.3. Obstetrics and Gynecology
6.1.6.4. Pain Management
6.1.6.5. Renal Procedures
6.1.6.6. Dermatologic Procedures
6.1.6.7. Podiatric Procedures
6.1.6.8. Dental and Maxillofacial Surgery
6.1.6.9. Other Specialty Procedures
What this section provides: This section maps consumable demand to underlying U.S. procedure volumes and helps clients identify clinical areas where case growth, increasing procedure complexity, and outpatient migration are creating the strongest recurring revenue opportunities.

7. U.S. Procedure-Based Medical Consumables Market – By Sterility & Configuration

7.1. Overview
7.1.1. Segment Share Analysis, By Sterility & Configuration, 2025 & 2035 (%)
7.1.2. Sterile Single-Use Consumables
7.1.2.1. Sterile Surgical Consumables
7.1.2.2. Sterile Vascular and Access Consumables
7.1.2.3. Sterile Injection and Infusion Consumables
7.1.2.4. Sterile Endoscopy Accessories
7.1.2.5. Sterile Diagnostic and Biopsy Consumables
7.1.2.6. Other Sterile Single-Use Products
7.1.3. Custom Procedure Trays and Integrated Kits
7.1.3.1. Surgical Procedure Packs
7.1.3.2. Cardiovascular and Interventional Packs
7.1.3.3. Endoscopy Procedure Packs
7.1.3.4. Anesthesia Packs
7.1.3.5. Orthopedic Procedure Packs
7.1.3.6. Ophthalmic Procedure Packs
7.1.3.7. Biopsy and Diagnostic Procedure Kits
7.1.3.8. Other Custom Procedure Kits
7.1.4. Non-Sterile Procedure Support Consumables
7.1.4.1. Protective Products
7.1.4.2. Preparation Products
7.1.4.3. External Procedure Accessories
7.1.4.4. Other Non-Sterile Procedure Products
7.1.5. Regulated Reprocessed Single-Use Devices
7.1.5.1. Reprocessed Surgical Devices
7.1.5.2. Reprocessed Cardiovascular and Electrophysiology Devices
7.1.5.3. Reprocessed Compression and Monitoring Accessories
7.1.5.4. Other FDA-Regulated Reprocessed Devices
What this section provides: This section evaluates the shift toward sterile single-use products, customized procedural configurations, and regulated reprocessing while quantifying how infection prevention, workflow simplification, sustainability, and hospital economics affect adoption.

8. U.S. Procedure-Based Medical Consumables Market – By End User

8.1. Overview
8.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
8.1.2. Hospitals and Integrated Health Systems
8.1.2.1. Academic Medical Centers
8.1.2.2. Tertiary and Quaternary Hospitals
8.1.2.3. Community Hospitals
8.1.2.4. Specialty Hospitals
8.1.2.5. Critical Access Hospitals
8.1.3. Ambulatory Surgery Centers
8.1.3.1. Multispecialty ASCs
8.1.3.2. Orthopedic ASCs
8.1.3.3. Ophthalmology ASCs
8.1.3.4. Gastroenterology ASCs
8.1.3.5. Pain Management ASCs
8.1.3.6. Urology and Other Specialty ASCs
8.1.4. Specialty Clinics and Office-Based Laboratories
8.1.4.1. Cardiovascular and Vascular OBLs
8.1.4.2. Urology Clinics
8.1.4.3. Pain Management Clinics
8.1.4.4. Dermatology and Minor Surgery Clinics
8.1.4.5. Other Specialty Practices
8.1.5. Endoscopy and Diagnostic Procedure Centers
8.1.5.1. Gastrointestinal Endoscopy Centers
8.1.5.2. Diagnostic Imaging Centers
8.1.5.3. Biopsy Centers
8.1.5.4. Interventional Diagnostic Centers
8.1.6. Other Procedural Care Settings
8.1.6.1. Dialysis Centers
8.1.6.2. Urgent Care Facilities
8.1.6.3. Maternity and Women’s Health Centers
8.1.6.4. Dental Surgical Facilities
8.1.6.5. Federal and Military Healthcare Facilities
What this section provides: This section identifies which care settings generate the greatest consumable demand and evaluates the impact of hospital consolidation, ASC expansion, office-based intervention, and procedure migration on supplier opportunity.

9. U.S. Procedure-Based Medical Consumables Market: Procurement, Supply Chain & Commercialization Analysis

9.1. Overview of U.S. Medical Consumables Procurement
9.2. Direct Hospital and Health System Contracting
9.3. Integrated Delivery Network Enterprise Agreements
9.4. Group Purchasing Organization Contracting
9.5. National and Regional Distributor Channels
9.6. Specialty Distributor and Procedure-Specific Supplier Channels
9.7. Ambulatory Surgery Center Procurement Models
9.8. Physician-Owned Facility Procurement Behavior
9.9. Custom Procedure Pack Contracting Models
9.10. Private-Label and OEM Consumables Strategy
9.11. Inventory Management and Automated Replenishment
9.12. Dual-Sourcing and Business Continuity Strategies
9.13. Domestic vs. Offshore Manufacturing Considerations
9.14. Supplier Qualification and Product Standardization
9.15. Procedure-Level Cost Benchmarking
9.16. Clinical Conversion and Product Switching Barriers
What this section provides: This section explains how procedure-based consumables are sourced, contracted, distributed, standardized, and replenished across U.S. health systems and ambulatory facilities, helping clients understand commercial access and supplier-selection dynamics.

10. U.S. Procedure-Based Medical Consumables Market – By Geography

10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional Procedure Volume and Healthcare Infrastructure Analysis
10.1.4. Hospital and ASC Density Analysis
10.1.5. Regional Procedure Migration Trends
10.1.6. Regional Procurement and Distribution Dynamics

10.2. West Region
10.2.1. Regional Overview & Trends
10.2.2. West Region Key Manufacturers, Distributors and Procurement Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By Sterility & Configuration, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.8. West Region Procedure Volume, ASC Expansion and Procurement Dynamics
10.2.9. California
10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Product Category, 2021–2035
10.2.9.3. California Market Size and Forecast, By Procedure Type, 2021–2035
10.2.9.4. California Market Size and Forecast, By Sterility & Configuration, 2021–2035
10.2.9.5. California Market Size and Forecast, By End User, 2021–2035
10.2.9.6. California Procedure Volume, Healthcare Infrastructure and Procurement Outlook
10.2.10. Washington
10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Product Category, 2021–2035
10.2.10.3. Washington Market Size and Forecast, By Procedure Type, 2021–2035
10.2.10.4. Washington Market Size and Forecast, By Sterility & Configuration, 2021–2035
10.2.10.5. Washington Market Size and Forecast, By End User, 2021–2035
10.2.10.6. Washington Procedure Volume, Healthcare Infrastructure and Procurement Outlook
10.2.11. Arizona
10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Product Category, 2021–2035
10.2.11.3. Arizona Market Size and Forecast, By Procedure Type, 2021–2035
10.2.11.4. Arizona Market Size and Forecast, By Sterility & Configuration, 2021–2035
10.2.11.5. Arizona Market Size and Forecast, By End User, 2021–2035
10.2.11.6. Arizona Procedure Volume, Healthcare Infrastructure and Procurement Outlook
10.2.12. Colorado
10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Product Category, 2021–2035
10.2.12.3. Colorado Market Size and Forecast, By Procedure Type, 2021–2035
10.2.12.4. Colorado Market Size and Forecast, By Sterility & Configuration, 2021–2035
10.2.12.5. Colorado Market Size and Forecast, By End User, 2021–2035
10.2.12.6. Colorado Procedure Volume, Healthcare Infrastructure and Procurement Outlook
10.2.13. Oregon
10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Product Category, 2021–2035
10.2.13.3. Oregon Market Size and Forecast, By Procedure Type, 2021–2035
10.2.13.4. Oregon Market Size and Forecast, By Sterility & Configuration, 2021–2035
10.2.13.5. Oregon Market Size and Forecast, By End User, 2021–2035
10.2.13.6. Oregon Procedure Volume, Healthcare Infrastructure and Procurement Outlook
10.2.14. Utah
10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Product Category, 2021–2035
10.2.14.3. Utah Market Size and Forecast, By Procedure Type, 2021–2035
10.2.14.4. Utah Market Size and Forecast, By Sterility & Configuration, 2021–2035
10.2.14.5. Utah Market Size and Forecast, By End User, 2021–2035
10.2.14.6. Utah Procedure Volume, Healthcare Infrastructure and Procurement Outlook
10.2.15. Nevada
10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Product Category, 2021–2035
10.2.15.3. Nevada Market Size and Forecast, By Procedure Type, 2021–2035
10.2.15.4. Nevada Market Size and Forecast, By Sterility & Configuration, 2021–2035
10.2.15.5. Nevada Market Size and Forecast, By End User, 2021–2035
10.2.15.6. Nevada Procedure Volume, Healthcare Infrastructure and Procurement Outlook
10.2.16. New Mexico
10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Product Category, 2021–2035
10.2.16.3. New Mexico Market Size and Forecast, By Procedure Type, 2021–2035
10.2.16.4. New Mexico Market Size and Forecast, By Sterility & Configuration, 2021–2035
10.2.16.5. New Mexico Market Size and Forecast, By End User, 2021–2035
10.2.16.6. New Mexico Procedure Volume, Healthcare Infrastructure and Procurement Outlook
10.2.17. Idaho
10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Product Category, 2021–2035
10.2.17.3. Idaho Market Size and Forecast, By Procedure Type, 2021–2035
10.2.17.4. Idaho Market Size and Forecast, By Sterility & Configuration, 2021–2035
10.2.17.5. Idaho Market Size and Forecast, By End User, 2021–2035
10.2.17.6. Idaho Procedure Volume, Healthcare Infrastructure and Procurement Outlook
10.2.18. Montana
10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Product Category, 2021–2035
10.2.18.3. Montana Market Size and Forecast, By Procedure Type, 2021–2035
10.2.18.4. Montana Market Size and Forecast, By Sterility & Configuration, 2021–2035
10.2.18.5. Montana Market Size and Forecast, By End User, 2021–2035
10.2.18.6. Montana Procedure Volume, Healthcare Infrastructure and Procurement Outlook
10.2.19. Wyoming
10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Product Category, 2021–2035
10.2.19.3. Wyoming Market Size and Forecast, By Procedure Type, 2021–2035
10.2.19.4. Wyoming Market Size and Forecast, By Sterility & Configuration, 2021–2035
10.2.19.5. Wyoming Market Size and Forecast, By End User, 2021–2035
10.2.19.6. Wyoming Procedure Volume, Healthcare Infrastructure and Procurement Outlook
10.2.20. Alaska
10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Product Category, 2021–2035
10.2.20.3. Alaska Market Size and Forecast, By Procedure Type, 2021–2035
10.2.20.4. Alaska Market Size and Forecast, By Sterility & Configuration, 2021–2035
10.2.20.5. Alaska Market Size and Forecast, By End User, 2021–2035
10.2.20.6. Alaska Procedure Volume, Healthcare Infrastructure and Procurement Outlook
10.2.21. Hawaii
10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Product Category, 2021–2035
10.2.21.3. Hawaii Market Size and Forecast, By Procedure Type, 2021–2035
10.2.21.4. Hawaii Market Size and Forecast, By Sterility & Configuration, 2021–2035
10.2.21.5. Hawaii Market Size and Forecast, By End User, 2021–2035
10.2.21.6. Hawaii Procedure Volume, Healthcare Infrastructure and Procurement Outlook

10.3. Northeast Region
10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Key Manufacturers, Distributors and Procurement Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035
10.3.4. Northeast Region Market Size and Forecast, By Product Category, 2021–2035
10.3.5. Northeast Region Market Size and Forecast, By Procedure Type, 2021–2035
10.3.6. Northeast Region Market Size and Forecast, By Sterility & Configuration, 2021–2035
10.3.7. Northeast Region Market Size and Forecast, By End User, 2021–2035
10.3.8. Northeast Region Procedure Volume, Academic Medical Center and Procurement Dynamics
10.3.9. New York
10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Product Category, 2021–2035
10.3.9.3. New York Market Size and Forecast, By Procedure Type, 2021–2035
10.3.9.4. New York Market Size and Forecast, By Sterility & Configuration, 2021–2035
10.3.9.5. New York Market Size and Forecast, By End User, 2021–2035
10.3.9.6. New York Procedure Volume, Healthcare Infrastructure and Procurement Outlook
10.3.10. Massachusetts
10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Product Category, 2021–2035
10.3.10.3. Massachusetts Market Size and Forecast, By Procedure Type, 2021–2035
10.3.10.4. Massachusetts Market Size and Forecast, By Sterility & Configuration, 2021–2035
10.3.10.5. Massachusetts Market Size and Forecast, By End User, 2021–2035
10.3.10.6. Massachusetts Procedure Volume, Healthcare Infrastructure and Procurement Outlook
10.3.11. New Jersey
10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Product Category, 2021–2035
10.3.11.3. New Jersey Market Size and Forecast, By Procedure Type, 2021–2035
10.3.11.4. New Jersey Market Size and Forecast, By Sterility & Configuration, 2021–2035
10.3.11.5. New Jersey Market Size and Forecast, By End User, 2021–2035
10.3.11.6. New Jersey Procedure Volume, Healthcare Infrastructure and Procurement Outlook
10.3.12. Pennsylvania
10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Product Category, 2021–2035
10.3.12.3. Pennsylvania Market Size and Forecast, By Procedure Type, 2021–2035
10.3.12.4. Pennsylvania Market Size and Forecast, By Sterility & Configuration, 2021–2035
10.3.12.5. Pennsylvania Market Size and Forecast, By End User, 2021–2035
10.3.12.6. Pennsylvania Procedure Volume, Healthcare Infrastructure and Procurement Outlook
10.3.13. Connecticut
10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Product Category, 2021–2035
10.3.13.3. Connecticut Market Size and Forecast, By Procedure Type, 2021–2035
10.3.13.4. Connecticut Market Size and Forecast, By Sterility & Configuration, 2021–2035
10.3.13.5. Connecticut Market Size and Forecast, By End User, 2021–2035
10.3.13.6. Connecticut Procedure Volume, Healthcare Infrastructure and Procurement Outlook
10.3.14. Maine
10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Product Category, 2021–2035
10.3.14.3. Maine Market Size and Forecast, By Procedure Type, 2021–2035
10.3.14.4. Maine Market Size and Forecast, By Sterility & Configuration, 2021–2035
10.3.14.5. Maine Market Size and Forecast, By End User, 2021–2035
10.3.14.6. Maine Procedure Volume, Healthcare Infrastructure and Procurement Outlook
10.3.15. Vermont
10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Product Category, 2021–2035
10.3.15.3. Vermont Market Size and Forecast, By Procedure Type, 2021–2035
10.3.15.4. Vermont Market Size and Forecast, By Sterility & Configuration, 2021–2035
10.3.15.5. Vermont Market Size and Forecast, By End User, 2021–2035
10.3.15.6. Vermont Procedure Volume, Healthcare Infrastructure and Procurement Outlook
10.3.16. New Hampshire
10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Product Category, 2021–2035
10.3.16.3. New Hampshire Market Size and Forecast, By Procedure Type, 2021–2035
10.3.16.4. New Hampshire Market Size and Forecast, By Sterility & Configuration, 2021–2035
10.3.16.5. New Hampshire Market Size and Forecast, By End User, 2021–2035
10.3.16.6. New Hampshire Procedure Volume, Healthcare Infrastructure and Procurement Outlook
10.3.17. Rhode Island
10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Product Category, 2021–2035
10.3.17.3. Rhode Island Market Size and Forecast, By Procedure Type, 2021–2035
10.3.17.4. Rhode Island Market Size and Forecast, By Sterility & Configuration, 2021–2035
10.3.17.5. Rhode Island Market Size and Forecast, By End User, 2021–2035
10.3.17.6. Rhode Island Procedure Volume, Healthcare Infrastructure and Procurement Outlook
10.3.18. Delaware
10.3.18.1. Overview
10.3.18.2. Delaware Market Size and Forecast, By Product Category, 2021–2035
10.3.18.3. Delaware Market Size and Forecast, By Procedure Type, 2021–2035
10.3.18.4. Delaware Market Size and Forecast, By Sterility & Configuration, 2021–2035
10.3.18.5. Delaware Market Size and Forecast, By End User, 2021–2035
10.3.18.6. Delaware Procedure Volume, Healthcare Infrastructure and Procurement Outlook

10.4. South Region
10.4.1. Regional Overview & Trends
10.4.2. South Region Key Manufacturers, Distributors and Procurement Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035
10.4.4. South Region Market Size and Forecast, By Product Category, 2021–2035
10.4.5. South Region Market Size and Forecast, By Procedure Type, 2021–2035
10.4.6. South Region Market Size and Forecast, By Sterility & Configuration, 2021–2035
10.4.7. South Region Market Size and Forecast, By End User, 2021–2035
10.4.8. South Region Procedure Growth, ASC Expansion and Procurement Dynamics
10.4.9. Texas
10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Product Category, 2021–2035
10.4.9.3. Texas Market Size and Forecast, By Procedure Type, 2021–2035
10.4.9.4. Texas Market Size and Forecast, By Sterility & Configuration, 2021–2035
10.4.9.5. Texas Market Size and Forecast, By End User, 2021–2035
10.4.9.6. Texas Procedure Volume, Healthcare Infrastructure and Procurement Outlook
10.4.10. Florida
10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Product Category, 2021–2035
10.4.10.3. Florida Market Size and Forecast, By Procedure Type, 2021–2035
10.4.10.4. Florida Market Size and Forecast, By Sterility & Configuration, 2021–2035
10.4.10.5. Florida Market Size and Forecast, By End User, 2021–2035
10.4.10.6. Florida Procedure Volume, Healthcare Infrastructure and Procurement Outlook
10.4.11. Georgia
10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Product Category, 2021–2035
10.4.11.3. Georgia Market Size and Forecast, By Procedure Type, 2021–2035
10.4.11.4. Georgia Market Size and Forecast, By Sterility & Configuration, 2021–2035
10.4.11.5. Georgia Market Size and Forecast, By End User, 2021–2035
10.4.11.6. Georgia Procedure Volume, Healthcare Infrastructure and Procurement Outlook
10.4.12. North Carolina
10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Product Category, 2021–2035
10.4.12.3. North Carolina Market Size and Forecast, By Procedure Type, 2021–2035
10.4.12.4. North Carolina Market Size and Forecast, By Sterility & Configuration, 2021–2035
10.4.12.5. North Carolina Market Size and Forecast, By End User, 2021–2035
10.4.12.6. North Carolina Procedure Volume, Healthcare Infrastructure and Procurement Outlook
10.4.13. Tennessee
10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Product Category, 2021–2035
10.4.13.3. Tennessee Market Size and Forecast, By Procedure Type, 2021–2035
10.4.13.4. Tennessee Market Size and Forecast, By Sterility & Configuration, 2021–2035
10.4.13.5. Tennessee Market Size and Forecast, By End User, 2021–2035
10.4.13.6. Tennessee Procedure Volume, Healthcare Infrastructure and Procurement Outlook
10.4.14. South Carolina
10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Product Category, 2021–2035
10.4.14.3. South Carolina Market Size and Forecast, By Procedure Type, 2021–2035
10.4.14.4. South Carolina Market Size and Forecast, By Sterility & Configuration, 2021–2035
10.4.14.5. South Carolina Market Size and Forecast, By End User, 2021–2035
10.4.14.6. South Carolina Procedure Volume, Healthcare Infrastructure and Procurement Outlook
10.4.15. Alabama
10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Product Category, 2021–2035
10.4.15.3. Alabama Market Size and Forecast, By Procedure Type, 2021–2035
10.4.15.4. Alabama Market Size and Forecast, By Sterility & Configuration, 2021–2035
10.4.15.5. Alabama Market Size and Forecast, By End User, 2021–2035
10.4.15.6. Alabama Procedure Volume, Healthcare Infrastructure and Procurement Outlook
10.4.16. Mississippi
10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Product Category, 2021–2035
10.4.16.3. Mississippi Market Size and Forecast, By Procedure Type, 2021–2035
10.4.16.4. Mississippi Market Size and Forecast, By Sterility & Configuration, 2021–2035
10.4.16.5. Mississippi Market Size and Forecast, By End User, 2021–2035
10.4.16.6. Mississippi Procedure Volume, Healthcare Infrastructure and Procurement Outlook
10.4.17. Louisiana
10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Product Category, 2021–2035
10.4.17.3. Louisiana Market Size and Forecast, By Procedure Type, 2021–2035
10.4.17.4. Louisiana Market Size and Forecast, By Sterility & Configuration, 2021–2035
10.4.17.5. Louisiana Market Size and Forecast, By End User, 2021–2035
10.4.17.6. Louisiana Procedure Volume, Healthcare Infrastructure and Procurement Outlook
10.4.18. Arkansas
10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Product Category, 2021–2035
10.4.18.3. Arkansas Market Size and Forecast, By Procedure Type, 2021–2035
10.4.18.4. Arkansas Market Size and Forecast, By Sterility & Configuration, 2021–2035
10.4.18.5. Arkansas Market Size and Forecast, By End User, 2021–2035
10.4.18.6. Arkansas Procedure Volume, Healthcare Infrastructure and Procurement Outlook
10.4.19. Kentucky
10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Product Category, 2021–2035
10.4.19.3. Kentucky Market Size and Forecast, By Procedure Type, 2021–2035
10.4.19.4. Kentucky Market Size and Forecast, By Sterility & Configuration, 2021–2035
10.4.19.5. Kentucky Market Size and Forecast, By End User, 2021–2035
10.4.19.6. Kentucky Procedure Volume, Healthcare Infrastructure and Procurement Outlook
10.4.20. Oklahoma
10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Product Category, 2021–2035
10.4.20.3. Oklahoma Market Size and Forecast, By Procedure Type, 2021–2035
10.4.20.4. Oklahoma Market Size and Forecast, By Sterility & Configuration, 2021–2035
10.4.20.5. Oklahoma Market Size and Forecast, By End User, 2021–2035
10.4.20.6. Oklahoma Procedure Volume, Healthcare Infrastructure and Procurement Outlook
10.4.21. Virginia
10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Product Category, 2021–2035
10.4.21.3. Virginia Market Size and Forecast, By Procedure Type, 2021–2035
10.4.21.4. Virginia Market Size and Forecast, By Sterility & Configuration, 2021–2035
10.4.21.5. Virginia Market Size and Forecast, By End User, 2021–2035
10.4.21.6. Virginia Procedure Volume, Healthcare Infrastructure and Procurement Outlook
10.4.22. Maryland
10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Product Category, 2021–2035
10.4.22.3. Maryland Market Size and Forecast, By Procedure Type, 2021–2035
10.4.22.4. Maryland Market Size and Forecast, By Sterility & Configuration, 2021–2035
10.4.22.5. Maryland Market Size and Forecast, By End User, 2021–2035
10.4.22.6. Maryland Procedure Volume, Healthcare Infrastructure and Procurement Outlook
10.4.23. West Virginia
10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Product Category, 2021–2035
10.4.23.3. West Virginia Market Size and Forecast, By Procedure Type, 2021–2035
10.4.23.4. West Virginia Market Size and Forecast, By Sterility & Configuration, 2021–2035
10.4.23.5. West Virginia Market Size and Forecast, By End User, 2021–2035
10.4.23.6. West Virginia Procedure Volume, Healthcare Infrastructure and Procurement Outlook

10.5. Midwest Region
10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Key Manufacturers, Distributors and Procurement Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035
10.5.4. Midwest Region Market Size and Forecast, By Product Category, 2021–2035
10.5.5. Midwest Region Market Size and Forecast, By Procedure Type, 2021–2035
10.5.6. Midwest Region Market Size and Forecast, By Sterility & Configuration, 2021–2035
10.5.7. Midwest Region Market Size and Forecast, By End User, 2021–2035
10.5.8. Midwest Region Procedure Volume, Health System Consolidation and Procurement Dynamics
10.5.9. Illinois
10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Product Category, 2021–2035
10.5.9.3. Illinois Market Size and Forecast, By Procedure Type, 2021–2035
10.5.9.4. Illinois Market Size and Forecast, By Sterility & Configuration, 2021–2035
10.5.9.5. Illinois Market Size and Forecast, By End User, 2021–2035
10.5.9.6. Illinois Procedure Volume, Healthcare Infrastructure and Procurement Outlook
10.5.10. Ohio
10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Product Category, 2021–2035
10.5.10.3. Ohio Market Size and Forecast, By Procedure Type, 2021–2035
10.5.10.4. Ohio Market Size and Forecast, By Sterility & Configuration, 2021–2035
10.5.10.5. Ohio Market Size and Forecast, By End User, 2021–2035
10.5.10.6. Ohio Procedure Volume, Healthcare Infrastructure and Procurement Outlook
10.5.11. Michigan
10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Product Category, 2021–2035
10.5.11.3. Michigan Market Size and Forecast, By Procedure Type, 2021–2035
10.5.11.4. Michigan Market Size and Forecast, By Sterility & Configuration, 2021–2035
10.5.11.5. Michigan Market Size and Forecast, By End User, 2021–2035
10.5.11.6. Michigan Procedure Volume, Healthcare Infrastructure and Procurement Outlook
10.5.12. Minnesota
10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Product Category, 2021–2035
10.5.12.3. Minnesota Market Size and Forecast, By Procedure Type, 2021–2035
10.5.12.4. Minnesota Market Size and Forecast, By Sterility & Configuration, 2021–2035
10.5.12.5. Minnesota Market Size and Forecast, By End User, 2021–2035
10.5.12.6. Minnesota Procedure Volume, Healthcare Infrastructure and Procurement Outlook
10.5.13. Indiana
10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Product Category, 2021–2035
10.5.13.3. Indiana Market Size and Forecast, By Procedure Type, 2021–2035
10.5.13.4. Indiana Market Size and Forecast, By Sterility & Configuration, 2021–2035
10.5.13.5. Indiana Market Size and Forecast, By End User, 2021–2035
10.5.13.6. Indiana Procedure Volume, Healthcare Infrastructure and Procurement Outlook
10.5.14. Wisconsin
10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Product Category, 2021–2035
10.5.14.3. Wisconsin Market Size and Forecast, By Procedure Type, 2021–2035
10.5.14.4. Wisconsin Market Size and Forecast, By Sterility & Configuration, 2021–2035
10.5.14.5. Wisconsin Market Size and Forecast, By End User, 2021–2035
10.5.14.6. Wisconsin Procedure Volume, Healthcare Infrastructure and Procurement Outlook
10.5.15. Missouri
10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Product Category, 2021–2035
10.5.15.3. Missouri Market Size and Forecast, By Procedure Type, 2021–2035
10.5.15.4. Missouri Market Size and Forecast, By Sterility & Configuration, 2021–2035
10.5.15.5. Missouri Market Size and Forecast, By End User, 2021–2035
10.5.15.6. Missouri Procedure Volume, Healthcare Infrastructure and Procurement Outlook
10.5.16. Iowa
10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Product Category, 2021–2035
10.5.16.3. Iowa Market Size and Forecast, By Procedure Type, 2021–2035
10.5.16.4. Iowa Market Size and Forecast, By Sterility & Configuration, 2021–2035
10.5.16.5. Iowa Market Size and Forecast, By End User, 2021–2035
10.5.16.6. Iowa Procedure Volume, Healthcare Infrastructure and Procurement Outlook
10.5.17. Kansas
10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Product Category, 2021–2035
10.5.17.3. Kansas Market Size and Forecast, By Procedure Type, 2021–2035
10.5.17.4. Kansas Market Size and Forecast, By Sterility & Configuration, 2021–2035
10.5.17.5. Kansas Market Size and Forecast, By End User, 2021–2035
10.5.17.6. Kansas Procedure Volume, Healthcare Infrastructure and Procurement Outlook
10.5.18. Nebraska
10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Product Category, 2021–2035
10.5.18.3. Nebraska Market Size and Forecast, By Procedure Type, 2021–2035
10.5.18.4. Nebraska Market Size and Forecast, By Sterility & Configuration, 2021–2035
10.5.18.5. Nebraska Market Size and Forecast, By End User, 2021–2035
10.5.18.6. Nebraska Procedure Volume, Healthcare Infrastructure and Procurement Outlook
10.5.19. North Dakota
10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Product Category, 2021–2035
10.5.19.3. North Dakota Market Size and Forecast, By Procedure Type, 2021–2035
10.5.19.4. North Dakota Market Size and Forecast, By Sterility & Configuration, 2021–2035
10.5.19.5. North Dakota Market Size and Forecast, By End User, 2021–2035
10.5.19.6. North Dakota Procedure Volume, Healthcare Infrastructure and Procurement Outlook
10.5.20. South Dakota
10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Product Category, 2021–2035
10.5.20.3. South Dakota Market Size and Forecast, By Procedure Type, 2021–2035
10.5.20.4. South Dakota Market Size and Forecast, By Sterility & Configuration, 2021–2035
10.5.20.5. South Dakota Market Size and Forecast, By End User, 2021–2035
10.5.20.6. South Dakota Procedure Volume, Healthcare Infrastructure and Procurement Outlook
What this section provides: This section delivers detailed regional and all-50-state analysis, helping clients identify priority U.S. markets, procedure-volume hubs, ASC expansion hotspots, hospital concentration, consumable utilization patterns, supply-chain requirements, and state-level commercial opportunities.

11. U.S. Procedure-Based Medical Consumables Market: Competitive Landscape & Company Profiles

11.1. Market Share Analysis, 2025
11.2. Company Positioning Matrix
11.2.1. Leaders
11.2.2. Challengers
11.2.3. Specialty Innovators
11.2.4. Emerging Players
11.3. Competitive Benchmarking by Product Portfolio
11.4. Competitive Benchmarking by Procedure Coverage
11.5. Competitive Benchmarking by U.S. Distribution Reach
11.6. Company Profiles
11.6.1. Medline Industries, LP
11.6.2. Cardinal Health, Inc.
11.6.3. Becton, Dickinson and Company
11.6.4. Baxter International Inc.
11.6.5. B. Braun Medical Inc.
11.6.6. Johnson & Johnson MedTech / Ethicon
11.6.7. Teleflex Incorporated
11.6.8. Terumo Medical Corporation
11.6.9. ICU Medical, Inc.
11.6.10. Owens & Minor, Inc.
11.6.11. Mölnlycke Health Care
11.6.12. Smith+Nephew
11.6.13. Solventum Corporation
11.6.14. Cook Medical
11.6.15. Merit Medical Systems, Inc.
11.6.16. Boston Scientific Corporation
11.6.17. Abbott Laboratories
11.6.18. Stryker Corporation
11.6.19. Olympus Corporation of the Americas
11.6.20. Fresenius Medical Care
11.6.21. Nipro Medical Corporation
11.6.22. Convatec Group Plc
11.6.23. Integra LifeSciences Holdings Corporation
11.6.24. Ansell Limited
11.6.25. McKesson Medical-Surgical
11.7. Company Profile Parameters
11.7.1. Company Overview
11.7.2. U.S. Procedure-Based Consumables Portfolio
11.7.3. Key Product Categories
11.7.4. Target Procedure Areas
11.7.5. U.S. Commercial and Distribution Strategy
11.7.6. Manufacturing and Sterilization Footprint
11.7.7. Financial Positioning
11.7.8. Recent Product Launches
11.7.9. Regulatory and Quality Updates
11.7.10. Partnerships, Acquisitions and Strategic Developments
What this section provides: This section gives clients competitive benchmarking, market-share visibility, portfolio positioning, procedure-area exposure, U.S. distribution strength, manufacturing capability, and strategic intelligence on 25 major market participants.

12. U.S. Procedure-Based Medical Consumables Market: Future Market Outlook, 2026–2035

12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic Scenario
12.1.3. Pessimistic Scenario
12.2. Disruptive Technology and Business Model Impact
12.2.1. Advanced Custom Procedure Trays
12.2.2. Smart and Digitally Trackable Consumables
12.2.3. Next-Generation Safety-Engineered Access Devices
12.2.4. Single-Use Endoscopic and Specialty Accessories
12.2.5. Advanced Wound Closure and Hemostasis Products
12.2.6. Sustainable Procedure Consumables and Packaging
12.2.7. Alternative Sterilization Technologies
12.2.8. Automated Procedure-Level Inventory Management
12.3. Future of Hospital Procedure Consumables Procurement
12.4. Future of ASC Consumables Procurement
12.5. Procedure Migration Impact Through 2035
12.6. U.S. Manufacturing Localization Outlook
12.7. Supply-Chain Resilience Outlook
12.8. Emerging Business Trends
12.9. Business Opportunities for Startups and Existing Players
12.10. Investment Prioritization Matrix
What this section provides: This section prepares clients for future procedure migration, product innovation, sterilization changes, supply-chain restructuring, digital inventory adoption, competitive disruption, and investment opportunities through 2035.

13. U.S. Procedure-Based Medical Consumables Market: Strategic Recommendations

13.1. Recommendations for Medical Consumables Manufacturers
13.2. Recommendations for Hospitals and Integrated Delivery Networks
13.3. Recommendations for Ambulatory Surgery Center Operators
13.4. Recommendations for Investors and Private Equity Firms
13.5. Recommendations for Distributors and Channel Partners
13.6. Recommendations for Contract Manufacturers and Sterilization Providers
13.7. Recommendations for New Entrants and Startups
13.8. Go-to-Market Strategy Considerations
13.9. Hospital and ASC Account Prioritization Strategy
13.10. Product Positioning and Portfolio Expansion Guidance
13.11. Custom Procedure Pack Commercialization Strategy
13.12. U.S. Geographic Expansion Strategy
13.13. Pricing and Contracting Strategy
13.14. Supply-Chain and Manufacturing Risk Mitigation Strategy
What this section provides: This section converts market intelligence into actionable recommendations for product portfolio design, commercialization, hospital and ASC penetration, geographic expansion, contracting, investment decisions, manufacturing strategy, and competitive differentiation.

14. U.S. Procedure-Based Medical Consumables Market: Disclaimer

14.1. Scope Limitation
14.2. Data Use Limitation
14.3. Forecasting Limitation
14.4. Procedure Volume Estimation Limitation
14.5. State-Level Market Estimation Limitation
14.6. Legal Disclaimer
14.7. Third-Party Data Disclaimer
What this section provides: This section clarifies the report’s methodological limitations, state-level modeling limitations, forecasting assumptions, legal boundaries, and data-use terms.

 

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Procedure-Based Medical Consumables Market: Market Definition and Scope
TABLE 3: U.S. Procedure-Based Medical Consumables Market: Research Methodology Framework
TABLE 4: U.S. Procedure-Based Medical Consumables Market: Key Assumptions
TABLE 5: U.S. Procedure-Based Medical Consumables Market: Market Ecosystem Overview
TABLE 6: U.S. Procedure-Based Medical Consumables Market: Stakeholder Analysis
TABLE 7: U.S. Procedure-Based Medical Consumables Market: Executive Summary Snapshot, 2025
TABLE 8: U.S. Procedure-Based Medical Consumables Market: Analyst Viewpoint Summary
TABLE 9: U.S. Procedure-Based Medical Consumables Market: Market Attractiveness Index
TABLE 10: U.S. Procedure-Based Medical Consumables Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 11: U.S. Procedure-Based Medical Consumables Market: Base Year Market Positioning, 2025
TABLE 12: U.S. Procedure-Based Medical Consumables Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 13: U.S. Procedure-Based Medical Consumables Market: High-Growth Opportunity Areas
TABLE 14: U.S. Procedure-Based Medical Consumables Market: Drivers; Impact Analysis
TABLE 15: U.S. Procedure-Based Medical Consumables Market: Restraints; Impact Analysis
TABLE 16: U.S. Procedure-Based Medical Consumables Market: Opportunities; Impact Analysis
TABLE 17: U.S. Procedure-Based Medical Consumables Market: Challenges; Impact Analysis
TABLE 18: U.S. Procedure-Based Medical Consumables Market: U.S. Procedure Volume Demand Matrix
TABLE 19: U.S. Procedure-Based Medical Consumables Market: ASC Procedure Migration Analysis
TABLE 20: U.S. Procedure-Based Medical Consumables Market: Patent & Innovation Analysis, 2021–2025
TABLE 21: U.S. Procedure-Based Medical Consumables Market: Clinical Workflow Economics Matrix
TABLE 22: U.S. Procedure-Based Medical Consumables Market: Consumable Cost per Procedure Analysis
TABLE 23: U.S. Procedure-Based Medical Consumables Market: Procedure Pack Standardization Economics
TABLE 24: U.S. Procedure-Based Medical Consumables Market: Hospital and ASC Procurement Behavior Matrix
TABLE 25: U.S. Procedure-Based Medical Consumables Market: PESTEL Analysis
TABLE 26: U.S. Procedure-Based Medical Consumables Market: Porter’s Five Forces Analysis
TABLE 27: U.S. Procedure-Based Medical Consumables Market: Pricing Trend Analysis by Region, 2025–2035
TABLE 28: U.S. Procedure-Based Medical Consumables Market: Value Chain Analysis
TABLE 29: U.S. Procedure-Based Medical Consumables Market: Supply Chain Analysis
TABLE 30: U.S. Procedure-Based Medical Consumables Market: Raw Material and Component Supply Landscape
TABLE 31: U.S. Procedure-Based Medical Consumables Market: Sterilization Services Landscape
TABLE 32: U.S. Procedure-Based Medical Consumables Market: Digital Inventory and UDI Tracking Impact
TABLE 33: U.S. Procedure-Based Medical Consumables Market: Application & Innovation Landscape
TABLE 34: U.S. Procedure-Based Medical Consumables Market: FDA Regulatory Framework Analysis
TABLE 35: U.S. Procedure-Based Medical Consumables Market: CMS Reimbursement and Procedure Payment Landscape
TABLE 36: U.S. Procedure-Based Medical Consumables Market: Medical Device Sterilization Regulatory Landscape
TABLE 37: U.S. Procedure-Based Medical Consumables Market: Import/Export Restrictions & Tariff Impact
TABLE 38: U.S. Procedure-Based Medical Consumables Market: Sustainability and Medical Waste Analysis
TABLE 39: U.S. Procedure-Based Medical Consumables Market: Geopolitical and Supply Continuity Risk
TABLE 40: U.S. Procedure-Based Medical Consumables Market: Hospital Value Analysis Committee Decision Framework
TABLE 41: U.S. Procedure-Based Medical Consumables Market: Product Category Snapshot, 2025
TABLE 42: Segment Dashboard; Definition and Scope, by Product Category
TABLE 43: U.S. Procedure-Based Medical Consumables Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 44: U.S. Procedure-Based Medical Consumables Market: Segment Share Analysis, by Product Category, 2025 & 2035 (%)
TABLE 45: Catheters, Guidewires and Procedural Access Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 46: Surgical and Wound-Closure Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 47: Procedure Packs, Drapes, Gowns and Barrier Products Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 48: Injection, Infusion and Fluid-Management Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 49: Biopsy, Sampling, Endoscopy and Specialty Procedure Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 50: U.S. Procedure-Based Medical Consumables Market: Procedure Type Snapshot, 2025
TABLE 51: Segment Dashboard; Definition and Scope, by Procedure Type
TABLE 52: U.S. Procedure-Based Medical Consumables Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 53: U.S. Procedure-Based Medical Consumables Market: Segment Share Analysis, by Procedure Type, 2025 & 2035 (%)
TABLE 54: Surgical Procedures Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 55: Interventional and Catheter-Based Procedures Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 56: Endoscopic Procedures Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 57: Diagnostic, Biopsy and Image-Guided Procedures Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 58: Specialty Procedures Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 59: U.S. Procedure-Based Medical Consumables Market: Sterility & Configuration Snapshot, 2025
TABLE 60: Segment Dashboard; Definition and Scope, by Sterility & Configuration
TABLE 61: U.S. Procedure-Based Medical Consumables Market, by Sterility & Configuration, 2021–2035 (US$ Billion)
TABLE 62: U.S. Procedure-Based Medical Consumables Market: Segment Share Analysis, by Sterility & Configuration, 2025 & 2035 (%)
TABLE 63: Sterile Single-Use Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 64: Custom Procedure Trays and Integrated Kits Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 65: Non-Sterile Procedure Support and Regulated Reprocessed Products Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 66: U.S. Procedure-Based Medical Consumables Market: End User Snapshot, 2025
TABLE 67: Segment Dashboard; Definition and Scope, by End User
TABLE 68: U.S. Procedure-Based Medical Consumables Market, by End User, 2021–2035 (US$ Billion)
TABLE 69: U.S. Procedure-Based Medical Consumables Market: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 70: Hospitals and Integrated Health Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 71: Ambulatory Surgery Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 72: Specialty Clinics and Office-Based Laboratories Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 73: Endoscopy, Diagnostic and Other Procedural Care Settings Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 74: U.S. Procedure-Based Medical Consumables Market: Procurement Ecosystem Snapshot, 2025
TABLE 75: U.S. Procedure-Based Medical Consumables Market: Direct Hospital Contracting Analysis
TABLE 76: U.S. Procedure-Based Medical Consumables Market: IDN Enterprise Contracting Analysis
TABLE 77: U.S. Procedure-Based Medical Consumables Market: Group Purchasing Organization Influence
TABLE 78: U.S. Procedure-Based Medical Consumables Market: Distributor and Specialty Supplier Landscape
TABLE 79: U.S. Procedure-Based Medical Consumables Market: ASC Procurement Model Analysis
TABLE 80: U.S. Procedure-Based Medical Consumables Market: Custom Procedure Pack Contracting Models
TABLE 81: U.S. Procedure-Based Medical Consumables Market: Private-Label and OEM Strategy
TABLE 82: U.S. Procedure-Based Medical Consumables Market: Domestic vs. Offshore Manufacturing Analysis
TABLE 83: U.S. Procedure-Based Medical Consumables Market: Supplier Qualification and Standardization Matrix
TABLE 84: U.S. Procedure-Based Medical Consumables Market: Product Conversion and Switching Barrier Analysis
TABLE 85: U.S. Procedure-Based Medical Consumables Market: Regional Snapshot, 2025
TABLE 86: Segment Dashboard; Definition and Scope, by Geography
TABLE 87: U.S. Procedure-Based Medical Consumables Market, by Region, 2021–2035 (US$ Billion)
TABLE 88: U.S. Procedure-Based Medical Consumables Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 89: U.S. Procedure-Based Medical Consumables Market: Regional Procedure Volume and Healthcare Infrastructure Analysis
TABLE 90: West Region U.S. Procedure-Based Medical Consumables Market: Regional Overview and Trends
TABLE 91: West Region U.S. Procedure-Based Medical Consumables Market, by State, 2021–2035 (US$ Billion)
TABLE 92: West Region U.S. Procedure-Based Medical Consumables Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 93: West Region U.S. Procedure-Based Medical Consumables Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 94: West Region U.S. Procedure-Based Medical Consumables Market, by Sterility & Configuration, 2021–2035 (US$ Billion)
TABLE 95: West Region U.S. Procedure-Based Medical Consumables Market, by End User, 2021–2035 (US$ Billion)
TABLE 96: California Procedure-Based Medical Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 97: Washington Procedure-Based Medical Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 98: Arizona Procedure-Based Medical Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 99: Colorado Procedure-Based Medical Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 100: Oregon Procedure-Based Medical Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 101: Utah Procedure-Based Medical Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 102: Nevada Procedure-Based Medical Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 103: New Mexico Procedure-Based Medical Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 104: Idaho Procedure-Based Medical Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 105: Montana Procedure-Based Medical Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 106: Wyoming Procedure-Based Medical Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 107: Alaska Procedure-Based Medical Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 108: Hawaii Procedure-Based Medical Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 109: Northeast Region U.S. Procedure-Based Medical Consumables Market: Regional Overview and Trends
TABLE 110: Northeast Region U.S. Procedure-Based Medical Consumables Market, by State, 2021–2035 (US$ Billion)
TABLE 111: Northeast Region U.S. Procedure-Based Medical Consumables Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 112: Northeast Region U.S. Procedure-Based Medical Consumables Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 113: Northeast Region U.S. Procedure-Based Medical Consumables Market, by Sterility & Configuration, 2021–2035 (US$ Billion)
TABLE 114: Northeast Region U.S. Procedure-Based Medical Consumables Market, by End User, 2021–2035 (US$ Billion)
TABLE 115: New York Procedure-Based Medical Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 116: Massachusetts Procedure-Based Medical Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 117: New Jersey Procedure-Based Medical Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 118: Pennsylvania Procedure-Based Medical Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 119: Connecticut Procedure-Based Medical Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 120: Maine Procedure-Based Medical Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 121: Vermont Procedure-Based Medical Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 122: New Hampshire Procedure-Based Medical Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 123: Rhode Island Procedure-Based Medical Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 124: Delaware Procedure-Based Medical Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 125: South Region U.S. Procedure-Based Medical Consumables Market: Regional Overview and Trends
TABLE 126: South Region U.S. Procedure-Based Medical Consumables Market, by State, 2021–2035 (US$ Billion)
TABLE 127: South Region U.S. Procedure-Based Medical Consumables Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 128: South Region U.S. Procedure-Based Medical Consumables Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 129: South Region U.S. Procedure-Based Medical Consumables Market, by Sterility & Configuration, 2021–2035 (US$ Billion)
TABLE 130: South Region U.S. Procedure-Based Medical Consumables Market, by End User, 2021–2035 (US$ Billion)
TABLE 131: Texas Procedure-Based Medical Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 132: Florida Procedure-Based Medical Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 133: Georgia Procedure-Based Medical Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 134: North Carolina Procedure-Based Medical Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 135: Tennessee Procedure-Based Medical Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 136: South Carolina Procedure-Based Medical Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 137: Alabama Procedure-Based Medical Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 138: Mississippi Procedure-Based Medical Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 139: Louisiana Procedure-Based Medical Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 140: Arkansas Procedure-Based Medical Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 141: Kentucky Procedure-Based Medical Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 142: Oklahoma Procedure-Based Medical Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 143: Virginia Procedure-Based Medical Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 144: Maryland Procedure-Based Medical Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 145: West Virginia Procedure-Based Medical Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 146: Midwest Region U.S. Procedure-Based Medical Consumables Market: Regional Overview and Trends
TABLE 147: Midwest Region U.S. Procedure-Based Medical Consumables Market, by State, 2021–2035 (US$ Billion)
TABLE 148: Midwest Region U.S. Procedure-Based Medical Consumables Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 149: Midwest Region U.S. Procedure-Based Medical Consumables Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 150: Midwest Region U.S. Procedure-Based Medical Consumables Market, by Sterility & Configuration, 2021–2035 (US$ Billion)
TABLE 151: Midwest Region U.S. Procedure-Based Medical Consumables Market, by End User, 2021–2035 (US$ Billion)
TABLE 152: Illinois Procedure-Based Medical Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 153: Ohio Procedure-Based Medical Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 154: Michigan Procedure-Based Medical Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 155: Minnesota Procedure-Based Medical Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 156: Indiana Procedure-Based Medical Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 157: Wisconsin Procedure-Based Medical Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 158: Missouri Procedure-Based Medical Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 159: Iowa Procedure-Based Medical Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 160: Kansas Procedure-Based Medical Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 161: Nebraska Procedure-Based Medical Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 162: North Dakota Procedure-Based Medical Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 163: South Dakota Procedure-Based Medical Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 164: U.S. Procedure-Based Medical Consumables Market: Competitive Landscape Snapshot, 2025
TABLE 165: U.S. Procedure-Based Medical Consumables Market: Key Company Market Share Analysis, 2025
TABLE 166: U.S. Procedure-Based Medical Consumables Market: Company Positioning Matrix
TABLE 167: U.S. Procedure-Based Medical Consumables Market: Product Portfolio Benchmarking of Key Players
TABLE 168: U.S. Procedure-Based Medical Consumables Market: Procedure Coverage Benchmarking of Key Players
TABLE 169: U.S. Procedure-Based Medical Consumables Market: U.S. Distribution Reach Benchmarking
TABLE 170: Medline Industries, LP: Company Profile
TABLE 171: Cardinal Health, Inc.: Company Profile
TABLE 172: Becton, Dickinson and Company: Company Profile
TABLE 173: Baxter International Inc.: Company Profile
TABLE 174: B. Braun Medical Inc.: Company Profile
TABLE 175: Johnson & Johnson MedTech / Ethicon: Company Profile
TABLE 176: Teleflex Incorporated: Company Profile
TABLE 177: Terumo Medical Corporation: Company Profile
TABLE 178: ICU Medical, Inc.: Company Profile
TABLE 179: Owens & Minor, Inc.: Company Profile
TABLE 180: Mölnlycke Health Care: Company Profile
TABLE 181: Smith+Nephew: Company Profile
TABLE 182: Solventum Corporation: Company Profile
TABLE 183: Cook Medical: Company Profile
TABLE 184: Merit Medical Systems, Inc.: Company Profile
TABLE 185: Boston Scientific Corporation: Company Profile
TABLE 186: Abbott Laboratories: Company Profile
TABLE 187: Stryker Corporation: Company Profile
TABLE 188: Olympus Corporation of the Americas: Company Profile
TABLE 189: Fresenius Medical Care: Company Profile
TABLE 190: Nipro Medical Corporation: Company Profile
TABLE 191: Convatec Group Plc: Company Profile
TABLE 192: Integra LifeSciences Holdings Corporation: Company Profile
TABLE 193: Ansell Limited: Company Profile
TABLE 194: McKesson Medical-Surgical: Company Profile
TABLE 195: U.S. Procedure-Based Medical Consumables Market: Future Market Scenario Analysis, 2026–2035
TABLE 196: U.S. Procedure-Based Medical Consumables Market: Disruptive Technology Impact Matrix
TABLE 197: U.S. Procedure-Based Medical Consumables Market: Hospital Procedure Consumables Procurement Outlook
TABLE 198: U.S. Procedure-Based Medical Consumables Market: ASC Consumables Procurement Outlook
TABLE 199: U.S. Procedure-Based Medical Consumables Market: Procedure Migration Impact, 2026–2035
TABLE 200: U.S. Procedure-Based Medical Consumables Market: U.S. Manufacturing Localization Outlook
TABLE 201: U.S. Procedure-Based Medical Consumables Market: Investment Prioritization Matrix
TABLE 202: U.S. Procedure-Based Medical Consumables Market: Strategic Recommendations for Manufacturers
TABLE 203: U.S. Procedure-Based Medical Consumables Market: Strategic Recommendations for Hospitals and IDNs
TABLE 204: U.S. Procedure-Based Medical Consumables Market: Strategic Recommendations for ASC Operators
TABLE 205: U.S. Procedure-Based Medical Consumables Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 206: U.S. Procedure-Based Medical Consumables Market: Strategic Recommendations for Distributors and Channel Partners
TABLE 207: U.S. Procedure-Based Medical Consumables Market: Strategic Recommendations for New Entrants
TABLE 208: U.S. Procedure-Based Medical Consumables Market: Go-to-Market Strategy Considerations
TABLE 209: U.S. Procedure-Based Medical Consumables Market: Product Positioning and Portfolio Expansion Guidance
TABLE 210: U.S. Procedure-Based Medical Consumables Market: Scope Limitation
TABLE 211: U.S. Procedure-Based Medical Consumables Market: Data Use Limitation
TABLE 212: U.S. Procedure-Based Medical Consumables Market: Forecasting Limitation
TABLE 213: U.S. Procedure-Based Medical Consumables Market: Procedure Volume Estimation Limitation
TABLE 214: U.S. Procedure-Based Medical Consumables Market: State-Level Estimation Limitation
TABLE 215: U.S. Procedure-Based Medical Consumables Market: Legal Disclaimer
TABLE 216: U.S. Procedure-Based Medical Consumables Market: Third-Party Data Disclaimer

List of Figures

FIGURE 1: U.S. Procedure-Based Medical Consumables Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: U.S. Procedure-Based Medical Consumables Market Ecosystem
FIGURE 4: U.S. Procedure-Based Medical Consumables Market Stakeholder Map
FIGURE 5: U.S. Procedure-Based Medical Consumables Market Size, Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 6: U.S. Procedure-Based Medical Consumables Market Size, Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 7: U.S. Procedure-Based Medical Consumables Market Year-wise Growth Curve, 2021–2035
FIGURE 8: U.S. Procedure-Based Medical Consumables Market Attractiveness Analysis
FIGURE 9: U.S. Procedure-Based Medical Consumables Market Dynamics
FIGURE 10: U.S. Surgical and Interventional Procedure Demand Framework
FIGURE 11: Hospital-to-ASC Procedure Migration Framework
FIGURE 12: Innovation & Patent Landscape, 2021–2025
FIGURE 13: Clinical Workflow Economics Framework
FIGURE 14: Consumable Cost per Procedure Framework
FIGURE 15: Hospital and ASC Procurement Decision Framework
FIGURE 16: PESTEL Analysis
FIGURE 17: Porter’s Five Forces Analysis
FIGURE 18: Value Chain Analysis
FIGURE 19: Supply Chain Analysis
FIGURE 20: Sterilization and Supply Continuity Framework
FIGURE 21: Digital Inventory and UDI Tracking Framework
FIGURE 22: Hospital Value Analysis Committee Decision Framework
FIGURE 23: Product Category Segment Market Share Analysis, 2025 & 2035
FIGURE 24: Product Category Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 25: Product Category Growth Opportunity Matrix
FIGURE 26: Procedure Type Segment Market Share Analysis, 2025 & 2035
FIGURE 27: Procedure Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 28: Procedure Type Growth Opportunity Matrix
FIGURE 29: Sterility & Configuration Segment Market Share Analysis, 2025 & 2035
FIGURE 30: Sterility & Configuration Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 31: Sterile Single-Use vs. Custom Procedure Kit Adoption Analysis
FIGURE 32: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 33: End User Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 34: Hospital vs. ASC Consumables Demand Outlook
FIGURE 35: U.S. Medical Consumables Procurement Ecosystem
FIGURE 36: GPO and IDN Contracting Influence Framework
FIGURE 37: Custom Procedure Pack Procurement Framework
FIGURE 38: Domestic vs. Offshore Supply Strategy Matrix
FIGURE 39: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 40: Regional Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 41: West Region Market Share Analysis by State, 2025
FIGURE 42: West Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 43: California Procedure-Based Medical Consumables Market Size Forecast, 2021–2035
FIGURE 44: Washington Procedure-Based Medical Consumables Market Size Forecast, 2021–2035
FIGURE 45: Arizona Procedure-Based Medical Consumables Market Size Forecast, 2021–2035
FIGURE 46: Colorado Procedure-Based Medical Consumables Market Size Forecast, 2021–2035
FIGURE 47: Oregon Procedure-Based Medical Consumables Market Size Forecast, 2021–2035
FIGURE 48: Utah Procedure-Based Medical Consumables Market Size Forecast, 2021–2035
FIGURE 49: Nevada Procedure-Based Medical Consumables Market Size Forecast, 2021–2035
FIGURE 50: New Mexico Procedure-Based Medical Consumables Market Size Forecast, 2021–2035
FIGURE 51: Idaho Procedure-Based Medical Consumables Market Size Forecast, 2021–2035
FIGURE 52: Montana Procedure-Based Medical Consumables Market Size Forecast, 2021–2035
FIGURE 53: Wyoming Procedure-Based Medical Consumables Market Size Forecast, 2021–2035
FIGURE 54: Alaska Procedure-Based Medical Consumables Market Size Forecast, 2021–2035
FIGURE 55: Hawaii Procedure-Based Medical Consumables Market Size Forecast, 2021–2035
FIGURE 56: Northeast Region Market Share Analysis by State, 2025
FIGURE 57: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 58: New York Procedure-Based Medical Consumables Market Size Forecast, 2021–2035
FIGURE 59: Massachusetts Procedure-Based Medical Consumables Market Size Forecast, 2021–2035
FIGURE 60: New Jersey Procedure-Based Medical Consumables Market Size Forecast, 2021–2035
FIGURE 61: Pennsylvania Procedure-Based Medical Consumables Market Size Forecast, 2021–2035
FIGURE 62: Connecticut Procedure-Based Medical Consumables Market Size Forecast, 2021–2035
FIGURE 63: Maine Procedure-Based Medical Consumables Market Size Forecast, 2021–2035
FIGURE 64: Vermont Procedure-Based Medical Consumables Market Size Forecast, 2021–2035
FIGURE 65: New Hampshire Procedure-Based Medical Consumables Market Size Forecast, 2021–2035
FIGURE 66: Rhode Island Procedure-Based Medical Consumables Market Size Forecast, 2021–2035
FIGURE 67: Delaware Procedure-Based Medical Consumables Market Size Forecast, 2021–2035
FIGURE 68: South Region Market Share Analysis by State, 2025
FIGURE 69: South Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 70: Texas Procedure-Based Medical Consumables Market Size Forecast, 2021–2035
FIGURE 71: Florida Procedure-Based Medical Consumables Market Size Forecast, 2021–2035
FIGURE 72: Georgia Procedure-Based Medical Consumables Market Size Forecast, 2021–2035
FIGURE 73: North Carolina Procedure-Based Medical Consumables Market Size Forecast, 2021–2035
FIGURE 74: Tennessee Procedure-Based Medical Consumables Market Size Forecast, 2021–2035
FIGURE 75: South Carolina Procedure-Based Medical Consumables Market Size Forecast, 2021–2035
FIGURE 76: Alabama Procedure-Based Medical Consumables Market Size Forecast, 2021–2035
FIGURE 77: Mississippi Procedure-Based Medical Consumables Market Size Forecast, 2021–2035
FIGURE 78: Louisiana Procedure-Based Medical Consumables Market Size Forecast, 2021–2035
FIGURE 79: Arkansas Procedure-Based Medical Consumables Market Size Forecast, 2021–2035
FIGURE 80: Kentucky Procedure-Based Medical Consumables Market Size Forecast, 2021–2035
FIGURE 81: Oklahoma Procedure-Based Medical Consumables Market Size Forecast, 2021–2035
FIGURE 82: Virginia Procedure-Based Medical Consumables Market Size Forecast, 2021–2035
FIGURE 83: Maryland Procedure-Based Medical Consumables Market Size Forecast, 2021–2035
FIGURE 84: West Virginia Procedure-Based Medical Consumables Market Size Forecast, 2021–2035
FIGURE 85: Midwest Region Market Share Analysis by State, 2025
FIGURE 86: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 87: Illinois Procedure-Based Medical Consumables Market Size Forecast, 2021–2035
FIGURE 88: Ohio Procedure-Based Medical Consumables Market Size Forecast, 2021–2035
FIGURE 89: Michigan Procedure-Based Medical Consumables Market Size Forecast, 2021–2035
FIGURE 90: Minnesota Procedure-Based Medical Consumables Market Size Forecast, 2021–2035
FIGURE 91: Indiana Procedure-Based Medical Consumables Market Size Forecast, 2021–2035
FIGURE 92: Wisconsin Procedure-Based Medical Consumables Market Size Forecast, 2021–2035
FIGURE 93: Missouri Procedure-Based Medical Consumables Market Size Forecast, 2021–2035
FIGURE 94: Iowa Procedure-Based Medical Consumables Market Size Forecast, 2021–2035
FIGURE 95: Kansas Procedure-Based Medical Consumables Market Size Forecast, 2021–2035
FIGURE 96: Nebraska Procedure-Based Medical Consumables Market Size Forecast, 2021–2035
FIGURE 97: North Dakota Procedure-Based Medical Consumables Market Size Forecast, 2021–2035
FIGURE 98: South Dakota Procedure-Based Medical Consumables Market Size Forecast, 2021–2035
FIGURE 99: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 100: Company Positioning Matrix
FIGURE 101: Key Player Product Portfolio Benchmarking
FIGURE 102: Key Player Procedure Coverage and U.S. Distribution Benchmarking
FIGURE 103: Strategic Developments, Partnerships, M&A and Product Launches
FIGURE 104: Future Market Scenario Analysis, 2026–2035
FIGURE 105: Disruptive Technology Impact Matrix
FIGURE 106: Hospital-to-ASC Procedure Migration Roadmap, 2026–2035
FIGURE 107: U.S. Procedure-Based Medical Consumables Innovation Roadmap
FIGURE 108: Investment Prioritization Matrix
FIGURE 109: Strategic Growth Roadmap for U.S. Procedure-Based Medical Consumables Companies
FIGURE 110: Go-to-Market Strategy Framework
FIGURE 111: Product Positioning and Portfolio Expansion Framework
FIGURE 112: Report Scope and Disclaimer Framework